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Summary 
This thesis is presented in two main parts.  Volume I is the research component 
comprising two papers: a literature review and empirical paper each concerned with the 
psychosocial effects of living with Coeliac Disease.  There is also a separate executive 
summary of both pieces of work.  Volume II is the clinical component, a compilation of 
five Clinical Practice Reports completed at the end of each clinical placement during the 3 
years of the Birmingham Clinical Psychology Course. 
 
Volume I 
The literature review is a systematic critique of empirical research published within 
the last decade to investigate the effects of living with CD in respect of psychological well-
being and Health Related Quality of Life (HRQoL).  Twenty-one relevant studies were 
identified with attention being paid to the methodology, outcome measures, type of CD 
and sample characteristics.   Difficulties when interpreting and comparing the results of the 
reviewed studies included differences in design and measures used, sample populations, 
country of origin, age group and duration of gluten-free diet. The reviewed data suggest 
that in addition to a reduced HRQoL, psychological distress, especially depressive 
symptoms is commonly found in people with CD.  Although anxiety is commonly 
experienced, this tends to decrease on a GFD.  However, depression may persist even in 
treated individuals.   
The empirical paper describes a postal survey aimed to explore the illness 
perceptions and self-efficacy beliefs of adults with CD in the UK and reports their 
subjective levels of HRQoL and psychological well-being.  Questionnaires were returned 
by 288 members of Coeliac UK and within this sample HRQoL and psychological well-
being were found to be reduced, with levels being comparable to those found in previous 
   
related studies.  Those participants with weak beliefs in the serious consequences of CD 
and reduced emotional reactions to the condition were more likely to experience an 
enhanced HRQoL, improved psychological well-being and increased self-efficacy.  The 
results suggest that perceived self-efficacy and illness perceptions could play an important 
role in informing psychological interventions for individuals with CD.  
 
Volume II 
Volume II contains the five Clinical Practice Reports (CPR’s) that focus on a 
combination of clinical perspectives and service issues relating to each placement.  CPR 5 
was presented orally so that only the abstract is included. 
CPR 1 presents two psychological formulations, each from a different theoretical 
perspective, concerning the problems of Katrina.  There are four main sections.  The first 
includes information relating to Katrina’s referral, assessment (including history) and her 
presenting problems.  In the second section, Katrina’s problems are formulated from a 
psychodynamic perspective based upon object relations theory and constructed using 
Malan’s triangles of conflict and person.  This is followed in section three, by an 
alternative cognitive behavioural formulation of health anxiety. The fourth and final 
section is a concise critique of the two different theoretical approaches used in each 
formulation and includes recommendations for improvements.  
CPR 2 describes a study carried out to evaluate clinical supervision groups set up for 
NHS nurses working in a continuing care unit for older adults.  National initiatives 
concerning supervision for nurses within the NHS and the available evidence for the 
effectiveness of this are considered.  The limitations of the methodology and the 
difficulties experienced in carrying out the evaluation are discussed and blocking factors 
are considered which might account for difficulties in implementing clinical group 
   
supervision for all staff.  Facilitative strategies are drawn from the relevant literature and 
recommendations are made for future evaluations and implementing supervision into 
routine clinical practice.   
CPR 3 concerns Christopher, a 9 year old boy referred to a Child and Adolescent 
Mental Health Service by his general practitioner with a request for help with long-term 
sleep difficulties. Details of the referral, assessment and formulation relevant to the case 
are presented.  These are followed by a description of the AB single-case experimental 
design that was employed to assess the effectiveness of a cognitive-behavioural 
intervention designed to increase Christopher’s total number of sleep hours per night and 
to reduce the time taken for him to fall asleep. 
CPR 4 presents the case of Marion a 58 year old woman with learning difficulties, 
who was reportedly displaying extreme eating behaviour by the over consumption of large 
quantities of food.  Background information on Marion’s personal and psychiatric history 
is provided.  This is followed by a formulation of the development and maintenance of 
Marion’s behaviour using cognitive-behavioural principles and a description of the 
interventions employed to manage her behaviour.  Finally there is an assessment of the 
outcome and reflections on the work with Marion and her care staff. 
CPR 5 was an orally presented report describing Tasmita a client who was referred to 
the CMHT where the trainee was on placement.  The scope of the presentation included the 
reasons for her referral, the assessment methods used, the rationale and theory behind the 
cognitive behavioural formulation of her difficulties and the evidence for and details of the 
proposed treatment plan.  The formulation described the development and maintenance of 
Tasmita’s depression and obsessive compulsive behaviours and was informed by the 
information obtained during the assessment stage.  This was followed by an evaluation of 
the cognitive behavioural treatment plan in terms of Tasmita’s own subjective experience.  
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Abstract 
Coeliac Disease (CD) is an autoimmune disease in which the enzyme gluten causes 
inflammation and damage to the small intestine. Untreated the condition may predispose 
symptomatic individuals to serious diseases such as cancer, type I diabetes, osteoporosis, 
gynaecological problems in women, peripheral and central nervous system disorders and 
other autoimmune diseases.  In Europe it is estimated that the condition may affect 
between 1 in 200 to 1 in 500 people. CD is incurable but symptoms are managed by a 
gluten-free diet (GFD) for life.    Most research looking at CD has focused on the 
biological basis of the disease rather than the impact of the condition from the individual’s 
subjective view. The few existing studies suggest that the chronicity of the condition, the 
limitations imposed by the need to follow a permanent restrictive diet and the risk of other 
associated diseases can have a negative impact on health-related quality of life (HRQoL) 
and psychological well-being.   However, knowledge in this area remains sparse to-date. 
The aim of this review was to systematically review the literature published within 
the last decade to investigate the effects of living with CD in respect of psychological well-
being and HRQoL.  Twenty-one relevant studies were identified and critically reviewed.  
Attention was paid to the methodology, outcome measures, type of CD and sample 
characteristics.   Difficulties when interpreting and comparing the results of the reviewed 
studies included differences in: design and measures used, sample populations, country of 
origin, age group, CD type, duration of GFD and adherence rates. The reviewed data 
suggest that in addition to a reduced HRQoL, psychological distress, especially self-
reported symptoms of depression are commonly found in individuals with CD.  Although 
anxiety symptoms are commonly experienced, these tend to decrease on a GFD.  However, 
depressive symptoms may persist even in treated individuals.   
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Introduction 
Coeliac Disease (CD) is an autoimmune disease in which the enzyme gluten, from 
wheat, barley and rye, causes damage and chronic inflammation to the small intestine 
leading to the malabsorption of nutrients.  People with the condition will have what is 
termed small-bowel villous atrophy or flattened villi (the tiny, finger like projections on the 
surface of the small intestine that help absorb nutrients).  This means their ability to absorb 
nutrients is severely restricted (Jones, 2007).  Untreated, CD may predispose symptomatic 
individuals to cancers such as small-bowel lymphoma (Egan, Stevens & McCarthy, 1996) 
non-Hodgkin’s lymphoma and other gastrointestinal cancers (West, Logan, Smith, 
Hubbard & Card, 2004).   The condition is also associated with type I diabetes, 
osteoporosis, gynaecological problems in women (Feighery, 2007) peripheral and central 
nervous system disorders (Cooke & Smith, 1966) and other autoimmune diseases 
(Ventura, Magazzu & Greco, 1999).   
Diagnosis is achieved through serologic testing (screening blood tests using a 
highly sensitive immunoglobulin A assay) followed by a biopsy of the small intestine 
(duodenum) to detect villous atrophy (Hopper et al, 2007).  CD can occur at any age, but in 
adults the peak incidence is in the fifth decade and females are more commonly affected 
than males (Jones, 2007).  In Europe it is estimated that CD may affect between 1 in 200 to 
1 in 500 people (Rewers, 2005; Catassi, Ratsch & Fabiani,  1994). This is comparable with 
prevalence rates in Canada (Cranney, Zarkadas, Graham & Switzer, 2003). However, some 
studies suggest a prevalence rate of 1 in 122 (Johnson, Watson, McMillan, Sloan & Love, 
1997) although many cases of the disease remain undiagnosed for many years leading to 
chronic ill-health (Ivarsson, Persson, Juto, Peltonen, Suhr & Hernell, 1999).  In the United 
States CD appears less prevalent, but this may be because the disease is under diagnosed 
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relative to Europe and the use of serologic testing is more common in Europe than the 
United States (Ferguson, 1997). 
Coeliac Disease has been classified into four phenotypes (Rostrom, Murray & 
Kagnoff, 2006).  In ‘classic’ CD, sufferers have intestinal malabsorption due to villous 
atrophy causing gastrointestinal symptoms including nausea, diarrhoea, bloating and 
abdominal pain. However, the ‘atypical’ (yet most common) form of the disease is 
asymptomatic with few or no gastrointestinal symptoms, but is characterized by other 
malabsorption problems including iron deficiency anaemia, osteoporosis, short stature and 
infertility (Goddard & Gillett, 2006).   In ‘silent’ CD individuals have no overt symptoms, 
but are found to have damaged intestinal villi caused by gluten in the diet.  This type of 
presentation may be discovered after serologic screening, endoscopy or duodenal biopsy 
for another reason.  In ‘latent disease’, individuals have a previous diagnosis of coeliac 
disease that responded to a gluten-free diet (GFD) and have normal intestinal mucosa. 
Latent CD can also represent individuals with currently normal intestinal mucosa on a 
gluten-containing diet who will subsequently develop CD. 
CD is incurable but is managed by a therapeutic GFD for life.  A gluten-free diet 
involves the complete avoidance of all foods made from or containing wheat, rye, barley 
and often oats; in some cases oats may be permitted (Haboubi, Taylor & Jones, 2006).  
Foods containing gluten include breads, pizza bases, biscuits, cakes, pastas, flours and 
cereals (Coeliac UK, 2008).  The GFD is very successful in managing the symptoms of CD 
as the removal of gluten allows the duodenal villi to re-grow, therefore leading to the 
normal absorption of nutrients (Mäki & Collin 1997).   
However, a diagnosis of CD and the start of a GFD can cause enormous changes in 
the lives of sufferers and the dietary restrictions can be hard to accept (Mäki & Collin, 
1997).  Those with the condition can feel restricted, isolated and at times anxious about 
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their food intake (Sverker, Hensing & Hallert, 2005) and adults with CD often report a 
poor quality of life (Hallert & Lohiniemi, 1999).  
Most research looking at CD has been focused on the biological basis of the disease 
and the autoimmune system (Cooper, Holmes & Kooke, 1978; Barone et al, 2007) and the 
long-term consequences of untreated CD (Dewar, Pereira & Ciclitira, 2004).  However, the 
growing interest in patient perspectives has stimulated research on subjective outcomes, 
particularly those that measure health-related quality of life (HRQoL) and psychological 
well-being (Hallert & Lohiniemi, 1999).  Consequently, the assessment of HRQoL is 
increasingly becoming an important outcome measure in clinical and epidemiological 
studies of gastroenterological disease (Hauser, Gold, Stallmach, Caspary & Stein, 2007).   
HRQoL is important for measuring the impact of chronic disease. The concept 
refers to an individual’s perceived state of health including social, emotional and physical 
well-being or functioning and incorporates positive and negative aspects of life 
(Fitzpatrick, Fletcher, Gore, Jones, Spiegelhalter & Cox, 1992).  In gastrointestinal disease 
the most relevant aspects of HRQoL tend to comprise primarily the subjective perception 
of relief of abdominal symptoms and secondarily the benefits of this relief on general well-
being and functional status (Hallert & Lohiniemi, 1999).  
HRQoL is a multi-dimensional dynamic concept that has developed from the need 
to assess the psychosocial impact of disease, which includes economic welfare, 
psychological well-being, social environment and health status (Sajid, Tonsi & Baig, 
2008).  The ‘health’ domain in HRQoL can range from negatively valued aspects of life, 
including anticipating death, to the more positively valued aspects such as role function or 
happiness.  Quality implies subjective evaluation by the individual.  The boundaries of this 
definition usually depend on the context and purpose of any particular assessment as well 
as the specific concerns of patients, clinicians and researchers (Guyatt, Feeny & Patrick, 
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1993).   The concept HRQoL is used when studying living with illness, rather than that of 
general QoL, because whilst widely valued aspects of life exist that are not generally 
considered as ‘health’, including income, freedom and quality of the environment, almost 
all of these aspects of life can become health related or affected when a person is living 
with illness (Guyatt et al, 1993).  Health-related quality-of-life (HRQOL) is still a loose 
definition and its relevant aspects may vary from study to study.  However, there is 
consensus that key dimensions of HRQoL are physical functions, sensations, self-
care/dexterity, cognition, pain/discomfort and emotional/psychological well-being i.e. “all 
within the skin” (Sajid et al, 2008).  Therefore, concepts such as health status, 
psychological distress and psychopathology can be viewed as specific facets amongst the 
many different aspects of HRQoL.   The World Health Organisation has defined HRQoL 
as: 
[…] an individual’s perception of their position in life in the context of 
the culture and value systems in which they live, in relation to their 
goals, expectations, standards and concerns.  It is a broad ranging 
concept affected in a complex way by the person’s physical health, 
psychological state, level of independence, social relationships and their 
relationships to salient features of the environment (WHO QOL-group, 
1996). 
 
 The few studies conducted so far concerned with various aspects of HRQoL in 
adults with coeliac disease, have been conducted in Canada, the USA and Europe most 
notably Italy, Germany and Scandinavia.  Studies from these countries suggest that 
depression (Ludvigson, Reutfors, Ösby, Ekbom & Montgomery, 2007) and lower quality 
of life (Addolorato et al, 2008) affect individuals with CD, and anxiety and depression 
have been identified as major causes of lower levels of adherence to treatment 
recommendations (for example, Addolorato et al, 1996; Holmes 1996).     
Scandinavian studies conducted in the early 1990’s cited by Hallert and Lohiniemi 
(1999) suggest that during the course of a therapeutic GFD, adults experience a detrimental 
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decline in subjective health and increased gastrointestinal symptoms and this tends to be 
most pronounced in females who score worse than non-coeliac women of the same age. 
However, knowledge of subjective health-related quality of life including self-perceived 
functional status of individuals diagnosed with CD remains sparse to-date and there is no 
literature that draws together the existing empirical studies conducted in Europe, Canada 
and the United States.  
 
Aims 
The main aim of this paper is to redress this situation by systematically reviewing 
empirical, peer reviewed studies published within the last decade that investigate the 
effects of living with CD in respect of various aspects of HRQoL including psychological 
well-being (a key dimension of this concept).  The literature will be critically reviewed to 
establish whether having coeliac disease and living on a GFD is associated with or has a 
detrimental effect on aspects of HRQoL and/or psychological wellbeing.  Attention will be 
paid to the methodology, outcome measures, type of CD and sample characteristics.  A 
further aim is to consider the implications of the results for clinical practice. 
 
Method 
Search strategy/selection of articles 
Pubmed/Medline, PsychInfo and CINAHL, were searched to identify literature on 
the psychosocial impact of Coeliac Disease on medically diagnosed adults published from 
1997 until 2008.  Search terms were ‘psychosocial’, ‘affective disorder’, ‘anxiety’, 
‘depression’, ‘quality of life’, ‘psychological adjustment’, ‘psychological well-being’, 
‘gluten-free diet’ and ‘coeliac/celiac disease’. References in the retrieved articles were 
further searched for relevant citations.  Prominent authors in the field were contacted by 
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email and asked for further relevant papers.  These searches resulted in a total of 264 hits 
to which the following criteria were applied: 
 
Year   Studies published during and after 1998. 
Sample  Adults medically diagnosed with coeliac disease. 
Study design Studies that include a control or reference group cohort or cross-
sectional studies. 
Measures Use of self-report measures of health-related quality of life 
(HRQoL) psychological well-being and/or distress. 
Exclusion Case studies, studies described in editorials, commentaries, or 
conference abstracts or other non peer reviewed studies, qualitative 
studies. Studies of adults focused on co-morbidities e.g. diabetes and 
irritable bowel syndrome. 
Language  Studies published in the English Language. 
 
 
Results 
The next section will give a brief overview of the studies, followed by a detailed 
description and critique, concluded by a final section that draws the findings together.   
 After applying the inclusion criteria and eliminating duplicate hits, 21 relevant 
empirical studies published between 1998 and 2008 were available for review. A 
description of the studies can be found in Table 1 and a full reference list can be found in 
Appendix 1.
Table 1 Characteristics and Main Findings of Included Studies 
 
Authors/ 
Year/ 
Country 
Design 
 
Target Group/ 
Sample Size 
Outcome 
Measures 
Gender Main Findings 
Ciacci et al, 
1998; Italy 
Retrospective 
case control: 
matched groups 
92 adults with biopsy 
proven CD; 48 with 
chronic persistent 
hepatitis; 100 healthy 
controls 
M-SDS CDG 70 ♀; 
CPH 34 ♀; 
CG 71♀ 
Depression scores significantly ↑ in CD 
groups compared to controls; age at 
diagnosis and compliance with diet did not 
correlate with depression. 
Hallert et al, 
1998; 
Sweden 
Retrospective 
cross-sectional:    
compared with 
normative data 
89 adult biopsy-proven 
coeliac patients on GFD 
versus normative 
population sample: 5277 
SF-36 
GSRS 
61% ♀ CDG; 
2713 ♀ CG 
After 10 years on a GFD, patients with CD 
had significantly lower SF-36 scores than 
general population. Low scoring confined to 
female patients.  
Addolorato 
et al, 2001; 
Italy 
Prospective: case-
control, matched 
groups. 
 
35 CD patients on GFD 
versus 59 healthy 
controls 
STAI 
M-SDS 
CDG 23 ♀; 
CG 32 ♀ 
At T0, pre-GFD, CD patients showed higher 
levels of state anxiety compared to controls. 
At T1 there was a significant drop in state 
anxiety in CD patients. 
Green et al, 
2001; USA 
Retrospective 
cross-sectional 
Survey 
1612 adults belonging to 
CD support groups across 
the north eastern regions 
in the United States. 75% 
biopsy proven CD. 
1 QoL item 
non-stan-
dardised 
Male-to-
female ratio 
1:2.8 
QoL after diagnosis rated as improved by 
77% of sample. 
Ciacci et al, 
2002; Italy 
Retrospective 
cohort:  
114 adults with treated 
CD: 25 with untreated 
disease. 
SAIC – 
developed by 
the authors + 
IBQ 
87 ♀ in 
treated CDG. 
Self-rated emotion data resulted in 3 factors: 
1 (fear, anger, anxiety & sadness) 2 
(reassurance & resignation) 
3 (relief) 
Hallert et al, 
2002; 
Sweden 
Retrospective, 
case-control:  
matched groups. 
 
34 men and 34 aged 
matched women with CD 
on GFD; 68 matched 
type-2 diabetes controls 
BI 
SF-36 
Male-to-
female ratio 
1:1 
Unlike women with diabetes, coeliac 
women (adhering to a GFD for several 
years) perceive the disease burden to be 
worse than men. 
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Table 1 continued/ … 
Authors/ 
Year/ 
Country 
Design 
 
Target Group/ 
Sample Size 
Outcome 
Measures 
Gender Main Findings 
Mustalahti et 
al 2002; 
Finland 
Prospective case-
control: un-
matched groups 
 
19 adults on GFD with 
screen detected CD; 21 
with symptom-detected 
CD; 105 healthy controls  
GSRS 
PGWBI 
Mostly ♀ GFD associated with improved QoL for 
symptom detected and screen-detected 
groups at 1 year. 
Usai et al 
2002; Italy 
Retrospective case-
control: matched 
groups 
68 patients with CD on 
GFD versus 136 healthy 
controls 
SF-36 CDG: 54 ♀ 
CG: 112 ♀ 
CD group obtained significantly worse 
scores than healthy controls on the SF-36 – 
GFD compliers showed better results than 
non-compliers 
Ciacci et al 
2003; Italy 
Retrospective 
cross-sectional 
581 members of 5 
regional coeliac societies 
SAIC 410 ♀ Coeliac disease not associated with a low 
level of self-perceived quality of life.  
Anxiety related to feeling different. 
Fera et al, 
2003; Italy 
Retrospective case-
control: matched 
groups  
 
3 groups of 100 patients: 
100 CD (biopsy proven) 
on GFD, 100 with 
diabetes and 100 healthy 
controls 
M-SDS 
STAI-Y1/Y2 
SF-36 
IBQ 
CDG: 75 ♀; 
DG 73 ♀ 
CG: 68 ♀ 
M-SDS & STAI-Y2 scores significantly 
higher in  patients with CD and diabetes 
than in healthy controls.  QoL was poorer in 
both CD and D patients than in controls & 
significantly correlated with anxiety. 
De Rosa et 
al, 2004; 
Italy 
Retrospective case-
control: matched 
group 
29 adult biopsy proven 
CD patients versus 47 
healthy comparisons  
IBQ 
EPQ 
PQ 
CDG 25 ♀; 
CG 40 ♀ 
More than 70% of the CD group scored in 
the pathological range on at least one scale 
of the IBQ. 
Johnston et al 
2004; 
Northern 
Ireland, UK 
Prospective case 
control: unmatched 
groups 
 
14 adults on GFD with 
screen-detected CD & 23 
controls; 17 clinically 
detected CD patients on 
GFD & 26  
SF-36 Mostly ♀ No significant differences on QoL between 
screen-detected CD group and controls and 
at 1 year follow-up.  
Siniscalchi et 
al, 2005; 
Italy 
Retrospective case 
control: healthy 
comparison group 
59 CD patients on GFD, 
71 CD patients on ND,  
80 healthy controls. 
M-SDS 
CFS 
FSS 
CDG 112 ♀ 
CG 63 ♀ 
All CD patients scored higher on depression 
and fatigue scales than healthy controls. 
In CD group on GFD, depression and 
fatigue scores did not significantly differ 
from CD group on ND. 
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Table 1 continued/… 
Authors/ 
Year/ 
Country 
Design 
 
Target Group/ 
Sample Size 
Outcome 
Measures 
Gender Main Findings 
Viljamaa et 
al, 2005; 
Finland 
Retrospective case 
control: unmatched 
groups 
 
81 CD screen detected 
adults versus 44 CD 
symptom detected adults; 
54 untreated CD patients; 
110 healthy adult 
controls 
PGWBI 
SF-36 
Greater 
number of  ♀ 
than men 
In screen detected participants QoL and 
gastro-intestinal symptoms were similar to 
those in symptom detected patients or non 
CD controls. 
Häuser et al 
2006; 
Germany 
Retrospective, 
cross-sectional  
survey 
446 members of the 
German Coeliac Society 
– biopsy proven 
diagnosis. 
SF-36 
HADS 
   
71.7% ♀ Despite a GFD, participants suffered a 
reduced HRQoL and a high burden of extra-
intestinal symptoms. 
Roos et al 
2006; 
Sweden 
Retrospective case-
control: matched 
groups 
 
51 medically diagnosed 
adults with CD on a GFD 
versus 182 age matched 
healthy adults 
PGWBI 59% ♀ CDG; 
57% ♀ CG 
Long treated adult CD participants showed 
no difference in psychological well-being to 
controls. 
Zarkadas et 
al 2006; 
Canada 
Retrospective 
cross-sectional  
survey 
2681 adult members of 
the Canadian Coeliac 
Association – biopsy 
proven diagnosis 
SF-12 + CD 
specific 
questions  
developed by 
authors. 
74.5% female QoL scores similar to normative data, but 
significantly lower for females and newly 
diagnosed participants. 
Addolorato et 
al, 2008; 
Italy 
Retrospective case 
control, matched 
groups 
 
40 adult-biopsy proven 
Classic CD patients: 25 
on GFD & 15 newly 
diagnosed versus 50 
healthy controls 
LSAS 
M-SDS 
35 female CD 
group: 40 
female 
controls 
Significantly higher prevalence of social 
phobia in CD patients compared to controls. 
Depression was present in a significantly 
higher percentage of CD patients compared 
to controls 
Casellas et al, 
2008; Spain 
Prospective cohort  
with internal 
controls 
Serological and symptom 
diagnosed adults with 
CD: 163 on GFD, 177 
newly diagnosed not on 
GFD 
2 HRQoL 
Scales: 
GIQLI 
EQ 
103 newly 
diagnosed 
females; 121 
GFD females 
GIQLI scores significantly better in patients 
on GFD; EQ scores significantly better in 
treated versus non-treated participants 
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Table 1 continued/… 
Authors/ 
Year/ 
Country 
Design 
 
Target Group/ 
Sample Size 
Outcome 
Measures 
Gender Main Findings 
Collin et al, 
2008; 
Finland 
Prospective case- 
control: non-
matched groups 
20 adult patients with 
biopsy proven CD on 
GFD versus 1199 non-
CD comparisons 
CCEI;  
TAS-20 
15 ♀ CD 
group: 50 
♀ controls 
Somatic anxiety higher in CD patients before 
GFD started. No alexithymia found, but scores 
improved at 1 year follow-up. Scores no 
different from comparisons. 
Nachman et 
al, 2008; 
Argentina 
Prospective case-
control, non- 
matched groups 
 
97 adults on GFD with 
classical CD symptoms; 
25 atypical symptoms/10 
silent CD; 70 healthy 
controls 
SF-36 
GSRS 
BDI 
117 ♀ 
across CD 
groups 
GFD produced substantial and rapid (3 month) 
improvement of most outcome measures in 
classical and atypical patients but not in silent 
cases.  All subgroups had similar 1-year scores 
to healthy controls 
 
Key to abbreviations:       Key to outcome measures cont’d: 
CDG  Coeliac Disease Group     EPQ  Eysenck Personality Questionnaire 
CG  Control/Comparison Group     EQ  EuroQol-5D 
CPH  Chronic Persistent Hepatitis     FSS  Fatigue Severity Scale 
DG  Diabetes Group      GIQLI  Gastrointestinal Quality of Life Index 
GFD  Gluten Free Diet       GSRS  Gastrointestinal Symptoms Rating Scale 
HRQoL Health-related Quality of Life    HADS  Hospital Anxiety and Depression Scale 
ND  Normal Diet       IBQ  Illness Behaviour Questionnaire 
♀  Women       LSAS  Liebowitz Social Anxiety Scale 
          M-SDS Modified Zung Self-Rating Depression Scale 
Key to outcome measures:       PGWBI Psychological General Wellbeing Index  
BDI  Beck Depression Inventory     PQ  Pychophysiological Questionnaire 
BI  Burden of Illness      SAIC  Self-Administered Inventory for Celiacs 
CCEI  Crown-Crisp Experiential Index     SF-12/36 Short Form-12/36 Health Survey 
CFS  Chronic Fatigue Scale      STAI  State-Trait Anxiety Inventory 
          TAS-20 Toronto Alexithymia Scale    
  
 
Country of origin  
 Eight studies originated from Italy, three from Sweden and three from Finland, 
with the remaining seven originating from Germany, the UK, Canada, the USA, Spain, 
Finland and Argentina. 
 
Gender   
Apart from one study where men and women were evenly matched, women were 
over-represented in the majority of the studies. 
 
Design of Studies 
 Table 2 below shows the methodological design of the included studies.  There are 
thirteen case-control studies: eight of these are retrospective and five prospective.  A 
further seven are cross-sectional and retrospective in design and the remaining two are 
cohort studies, one prospective and the other retrospective. 
 
Table 2  Design of Studies Included in the Review 
Sampling Method Prospective Studies Retrospective Studies 
 
Case-control/comparison 
 
 
Addolorato et al, 2001 
Mustalahti et al, 2002 
Johnston et al, 2004 
Collin et al, 2008 
Nachman et al, 2008 
 
 
Ciacci et al, 1998 
Hallert et al, 2002 
Usai et al, 2002 
Fera et al, 2003 
De Rosa et al, 2004 
Siniscalchi et al, 2005 
Viljamaa et al, 2005 
Addolorato et al, 2008 
 
Cohort 
 
 
Casellas et al, 2008 
 
 
Ciacci et al, 2002 
 
Cross-sectional 
 
  
Hallert et al, 1998 
Green et al, 2001 
Ciacci et al 2003 
Häuser et al 2006 
Roos et al 2006 
Zarkadas et al 2006 
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Sample Characteristics 
The samples in the majority of the studies were drawn from hospital populations 
apart from four national surveys that recruited participants from Coeliac Support Group 
networks. Size was variable depending on study design (please see Table 1) although 
prospective studies tended to have less than adequate numbers. 
 
Type of Coeliac Disease 
All participants in the studies had either biopsy proven and/or serologically 
detected CD.  Only one study distinguished between classical CD symptoms, atypical 
symptoms and Silent Disease and another referred to participants as those with classic 
form CD.  
 
Outcome Measures 
Table 3 overleaf, shows the different self-report outcome measures chosen in each 
study to assess psychological distress and/or HRQoL (please see Appendix 2 for a glossary 
of abbreviations and referenced list of measures).  Eight studies focused on psychological 
symptoms and/or psychiatric problems in CD, a further nine studies were concerned 
exclusively with assessing HRQoL, the majority using measures specifically designed to 
measure physical and emotional functioning. Four studies used specific measures to 
explore psychological distress and generic multi-item scales to assess HRQoL.   
The majority of studies that used standardised measures of HRQoL focused on the 
effects of living on and adhering to a gluten free diet.  The most commonly used 
instrument for measuring HRQoL was the Short Form 36 Health Survey (SF-36) that was 
used in eight studies.  For investigating patient self-reported symptoms the modified Zung 
Self-Rating Depression Scale (M-SDS) was employed in five studies. The three items of 
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this scale that evaluated gastro-enteric symptoms of depression (decreased appetite, weight 
loss & constipation) were omitted to avoid bias.   The Illness Behaviour Questionnaire 
(IBQ) was also used in three different studies as was the Psychological General Well-being 
Index (PGWBI).  Apart from the previous examples, in general there was little consistency 
in terms of outcome measures employed across the 21 reviewed studies.      
Table 3 Research focus and self-report (S-R) measures used in the included studies  
Studies of Psychological and/or Psychiatric Factors in CD 
Study Focus    S-R Outcome Measures Authors 
Depressive Symptoms  M-SDS   Ciacci et al, 1998 
Anxiety & Depression on GFD STAI, M-SDS   Addolorato et al, 2001 
Psychological dimensions  SAIC, IBQ   Ciacci et al, 2002 
Illness Behaviour & Personality IBQ, EPQ, PQ   De Rosa et al,  2004 
Fatigue & Depression   M-SDS, CFS, FSS  Siniscalchi et al, 2005  
Psychological well being  PGWBI   Roos et al, 2006  
Social Phobia & Depression  LSAS, M-SDS  Addolorato et al, 2008 
Alexithymia & Anxiety  CCEI; TAS-20  Collin et al, 2008 
 
Studies of Health Related Quality of Life in CD 
Study Focus    S-R Outcome Measures Authors 
Impact of GFD    SF-36, GSRS   Hallert et al, 1998 
Clinical spectrum of CD & QoL Non-standardised scale Green et al, 2001 
Impact of GFD   SF-36, BI   Hallert et al, 2002 
Impact of GFD    GSRS, PGWBI  Mustalahti et al, 2002 
Adherence (or not) to a GFD  SF-36    Usai et al, 2002 
Impact of GFD   SAIC    Ciacci et al, 2003 
Impact of GFD   SF-36    Johnston et al, 2003 
Impact of GFD   SF-12, authors’ own  Zarkadas et al, 2006  
Impact of GFD   GIQLI, EQ   Casellas et al, 2008 
 
Studies of Quality of Life and Psychological Distress in CD 
Study Focus    S-R Outcome Measures Authors 
Effects of GFD on QoL   M-SDS, SF-36, IBQ  Fera et al, 2003 
& mood disturbance   STAI-Y1/Y2 
 
Impact of dietary compliance  PGWBI, SF-36  Viljamaa et al, 2005 
on QoL & mental health 
 
Clinical spectrum of CD,  SF-36, HADS,   Hauser et al, 2006 
HRQoL & mood disorders   
 
Time-course impact of GFD  SF-36, GSRS, BDI  Nachman et al, 2008 
On QoL and depression 
 
For key to outcome measures please see table 1
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Main Review 
Studies using self-report measures of psychological factors and psychiatric disorders  
Ciacci, Iavarone, Mazzacca & De Rosa (1998) found depressive symptoms in 
young adult out-patients with CD compared to a healthy control group measured by the M-
SDS.  The depressive symptoms were not influenced by age at diagnosis, gender, 
socioeconomic variables, duration of or self-reported adherence to a GFD.  The average 
duration of GFD was 7.9 years.  The authors suggest that depressive symptoms are a 
feature of CD and are related to living with the condition rather than to an organic cause 
i.e. not a consequence of brain function disorders due to intestinal malabsorption.   A 
disadvantage of this retrospective case-control study is that although it may prove an 
association between CD and depressive symptoms, it does not demonstrate causation.    
In a longitudinal study Addolorato et al (2001) studied individuals with CD before 
and after a year on a GFD.  The presence of symptoms of anxiety and depression were 
assessed with the STAI and M-SDS respectively and compared to healthy matched 
controls.  At baseline, a significantly higher percentage of individuals with CD showed 
high levels of state anxiety compared to controls but no significant difference was found in 
trait anxiety.  The percentage of individuals with CD who reported depressive symptoms 
was also significantly higher compared to controls.  At 1 year follow-up a significant 
decrease was found in the percentage of state anxiety in individuals with CD compared to 
controls.  There were no significant changes in trait anxiety or depression, the latter 
remaining significantly higher in treated (GFD) individuals with CD.  The authors 
concluded that in people with CD, anxiety exists in a ‘reactive form’ (rather than as a 
personality trait) and decreases after starting a GFD.  They suggest that the symptoms of 
depression that remained present in treated individuals could be attributed to the reduction 
in quality of life related partly to a decreased feeling of well-being and also due to dietary 
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restrictions leading to difficulties in daily social relationships.  For example, not being able 
to eat the same food as one’s peers can lead to a reduced social life and feelings of 
inadequacy and difference.  A limitation to this otherwise sound study is the relatively 
brief follow-up period of 1 year after adherence to a GFD.  A longer follow-up period 
would allow for the exploration of the persistence of depressive symptoms in people with 
CD.  
In a study by Ciacci, Iavarone, Siniscalchi, Romano & De Rosa (2002) the 
emotional impact of a diagnosis of CD in adulthood was explored.  Using a questionnaire 
developed by the authors (SAIC) the psychological and emotional aspects of living with 
CD were investigated.  Scores of self-rated emotions were entered into a principal 
components analysis that generated 3 factors: (1) fear, anger, anxiety & sadness; (2) 
reassurance & resignation; (3) relief.  Anger was found to represent the predominant 
emotion that reduced adherence to GFD and led individuals to transgress. Significant 
positive correlations were found between ‘feeling different’ and sadness, anger, fear and 
anxiety.  The non-heterogeneous sample in this study that included twenty five untreated 
individuals with CD is a significant weakness.  Furthermore, the items of the SAIC 
measure (some based on a less robust visual analogue scale) were only partially validated 
against similar questions of the Illness Behaviour Questionnaire (IBQ) completed by 
twenty seven individuals with CD.  
De Rosa, Troncone, Vacca & Ciacci (2004) used the IBQ to investigate the influence 
of CD and its treatment on key personality components and adherence to a GFD.  Other 
measures were the EPQ and PQ.   The latter instrument explores level of stress-induced 
emotional activation. The IBQ scales on which the highest number of individuals had 
scores in the pathological range were ‘affective inhibition’ and ‘irritability’.  The EPQ 
scores of individuals with CD differed significantly from controls on the P scale 
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(psychoticism) and the L scale (lie scale). On the PQ, individuals who received a diagnosis 
in adulthood had significantly higher scores than the healthy controls. On the basis of these 
results, the authors suggest that CD is associated with a ‘Coeliac Profile’ composed of two 
main characteristics: (1) irritability with related psychophysiological reactiveness and (2) a 
type of conformism that reflects difficulty in expressing personal feelings and the desire to 
have a good self-image.  They conclude that this profile characterises a lifestyle limited by 
chronic disease.  However, 86% of their sample were women thus biasing these results. 
 In a study to evaluate the prevalence of fatigue, Siniscalchi et al (2005) 
administered the M-SDS, the CFS and the FSS to treated versus untreated out-patients with 
CD and healthy controls.  They found that all the individuals with CD had significantly 
higher M-SDS depression scores and greater CFS scores compared with controls.  Those 
individuals on a GFD had significantly higher depression scores than those in the non-
treated CD group.  The prevalence of clinically significant levels of depression in all 
individuals with CD was 17% compared to 0% in healthy controls.  The authors also found 
a significant correlation between depression scores and fatigue scale scores in the non-
treated CD group.  In the GFD group, fatigue scale scores did not differ significantly from 
those on a normal diet and were not related to dietetic compliance.  The authors state that 
fatigue is a common finding in people with CD and emphasise that depressive symptoms in 
individuals on a GFD seem to persist, supporting previous observations that a GFD alone 
does not significantly reduce the percentage of people with CD affected by low mood 
(Ciacci et al, 1998).  
Roos, Kärner and Hallert (2006) used the PGWBI to assess the psychological well-
being of middle aged adults with CD who had adhered to a GFD for at least ten years.  
Compared to controls, those with CD showed no more signs of anxiety, depressed mood or 
distress. However, unlike controls women with CD showed significantly lower scores on 
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the PGWBI than their male counterparts, most notably within the ‘Vitality’ sub-scale.  
Based on previous qualitative research the authors hypothesised that women with CD may 
perceive the burden of their disease as significantly worse than men in terms of inhibiting 
socialising with friends and having to abstain from other important activities of daily 
living.  
The presence of social phobia (an anxiety disorder) and depressive symptoms in 
individuals with CD was investigated by Addolorato et al (2008) using the LSAS and M-
SDS.  The authors found that the percentage of participants with mild and severe social 
phobia was significantly higher in those with CD compared to healthy controls.  There 
were no significant differences either for mild or severe social phobia between newly 
diagnosed, un-treated participants and those on a GFD.  Depressive symptoms were also 
found in a significantly higher proportion of individuals with CD than controls and there 
was a direct correlation between social phobia and depressive symptoms in the CD group.  
The authors suggest several reasons for the onset of social phobia in individuals with CD.  
For instance, before diagnosis, the main symptoms of CD such as abdominal pain, 
diarrhoea and weight loss are often reported as the reasons for work and relationship 
difficulties.  In addition there is a common fear of being judged as a sick person.  As time 
progresses, the restricted lifestyle associated with a GFD might increase feelings of being 
different in relation to others and could result in a substantially reduced social life. The 
authors also suggest that the avoidance of social activities and public situations might lead 
to the development of depression. However, as the authors mention, the lack of a 
comparison group of individuals affected by another disease makes it impossible to assess 
whether social phobia is related to CD per se or to general symptoms.   
 Collin, Kaukinen, Mattila & Joukamaa (2008) evaluated whether individuals with 
CD suffer from psychoneurotic symptoms or alexithymia.  Alexithymia is associated with 
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various gastrointestinal disorders and refers to a personality construct characterised by 
impoverished fantasy, a poor capacity for symbolic thought and an inability to experience 
and verbalise feelings.  The CCEI which has six sub-scales was used to measure neurotic 
psychopathology (including depression and anxiety) and the 20-item version of the 
Toronto Alexithymia Scale (TAS-20) was used to measure alexithymia in a small sample 
of adults with CD before and after commencing a GFD.  It was found that somatic anxiety 
was higher in individuals with CD before the introduction of the GFD than after adhering 
to the diet for one year.  GFD had no other significant effect on CCEI scores.  There was 
no evidence of alexithymia, but TAS-20 scores improved significantly at one year follow-
up.  Individuals’ scores did not differ from published Finnish population estimates.  The 
authors observe that these findings do not support studies from other countries where 
depression has been more commonly found in people with CD.  They suggest that as their 
sample had only minor coeliac-related symptoms and excellent GFD adherence rates, this 
may have influenced the results. In addition, they state that there is much more common 
knowledge about CD in their country (Finland) where there is a high clinical prevalence of 
the disease and where gluten-free alternatives are more widely available commercially and 
in restaurants. 
Amongst these eight studies above, the majority used validated measures of 
depression and/or anxiety.  Apart from 2 prospective studies (Addolorato et al, 2001 and 
Collin et al, 2008) the remainder were all retrospective in design.  In the studies using the 
M-SDS (including one prospective study) the presence of depressive symptoms was found 
in  individuals with CD compared to controls.  In the prospective study (Collin et al, 2008) 
depression and state anxiety were higher before commencement of a GFD compared to 
controls.  At 1-year follow-up anxiety decreased but depression persisted.   In a 
retrospective study using the PGWBI (Roos et al, 2006) individuals with CD were found to 
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be no more anxious or depressed than healthy controls.  However, women with CD showed 
lower scores than their male counterparts.  In the remaining Italian prospective study, 
compared to controls, somatic anxiety, but not depression was higher in individuals with 
CD before the introduction of a GFD than after 1-year follow-up on treatment.    
 
Studies using self-report measures of Health Related Quality of Life (HRQoL)  
Hallert et al (1998) used the SF-36 to assess the subjective health status of adults with 
CD who had been on a GFD for 10 years. Those shown to be in histological remission 
were also assessed on the GSRS.  The SF-36 scores of female participants with CD were 
significantly lower than those of the general population, particularly in the General Health 
and Vitality sub-scales suggesting poor subjective health and excessive tiredness.  Female 
participants also reported significantly more gastrointestinal symptoms than males as 
measured by the GSRS.  In contrast, men with CD scored higher than their male 
counterparts in the general population on most of the SF-36 scales, particularly on Bodily 
Pain and Social Functioning domains. The reported dietary compliance rate for all 
participants with CD was 78% and this was corroborated by biopsy. The authors expressed 
surprise that after 10 years on a GFD, females with CD failed to achieve the subjective 
health status reported by the general Swedish population, but hypothesise that men and 
women may cope differently with the social inconvenience to their daily activities caused 
by dietary restrictions as indicated by the difference in scores on the Social Functioning 
domain of the SF-36. In an extension of the above study, Hallert et al (2002) investigated 
possible gender differences in perceived illness burden.  They studied individuals with CD 
and matched type-2 diabetes controls treated for an average of ten years.  Participants 
completed the 9-item Burden of Illness (BI) protocol comprising perceived worries, 
restrictions and subjective outcome.  This measure was developed by the authors on the 
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basis of many years of clinical experience with adults diagnosed with CD.  Cronbach’s 
alpha reliability coefficient for the instrument was 0.73 showing good internal consistency.  
Construct validity was provided by a fair agreement with the PGWB index.  Subjective 
health was also assessed with the SF-36.  The results indicated that the importance of 
complying with a GFD was ranked high by male and female participants.  However, 
women were less satisfied with the outcome after ten years than men and tended to express 
more concern about the impact on socialising with friends and the resulting abstention 
from important things in life.  None of these concerns distinguished between males and 
females with diabetes.  Women with CD had higher BI sum scores than men and this was 
inversely related to the SF-36 General Health, Mental Health and Vitality scores.  The 
authors concluded that women with CD adhering to a GFD perceive the disease burden to 
be worse compared to men and the perception of restriction is a prominent feature of the 
disease burden.  As the authors state, the weakness of the study is the lack of a control 
group that shares key features of CD. 
In a large cross-sectional survey Green et al (2001) aimed to investigate the clinical 
spectrum of adults with CD in the USA.  They distributed a multiple choice questionnaire 
in a newsletter directly to CD support groups and via the internet.   The survey focused 
predominantly on the general characteristics of respondents rather than evaluating 
psychological well-being and/or HRQoL.   However, to assess the effects of adhering to a 
GFD, the authors devised a single-item question concerning self-perceptions of QoL before 
and after diagnosis.  Quality of life before diagnosis was rated as bad by 30%, fair 33%, 
good 24% and excellent 10%.  After diagnosis QoL was reported to be improved by 77%, 
unchanged by 15% and worse by 8%.  The majority of participants had a long duration of 
symptoms before the diagnosis was confirmed, probably due to the perception among 
clinicians that the disease is rare.  Due to the limitations of the one-dimensional, non-
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validated measure used, it is not possible to draw any firm conclusions from this survey 
concerning HRQoL.  
Mustalahti and colleagues (2002), evaluated the effect of a GFD on the HRQoL of a 
small sample of individuals with screen-detected CD and those with symptom-detected 
disease, before and one year after initiation of a GFD.  Participants completed the GSRS to 
assess symptoms and the PGWB to measure QoL.  At baseline the authors found that 
participants with symptom-detected disease had poorer QoL and more gastrointestinal 
symptoms than those with screen detected CD.  Reported compliance with the GFD was 
good in both groups (93% symptom detected and 95% screen-detected).  HRQoL for 
participants in both groups was significantly improved after one year of a GFD.  Similarly, 
GSRS scores were also improved in both groups.  The authors concluded that a GFD was 
associated with improved HRQoL for participants with symptom-detected CD and those 
with screen-detected disease and that concerns about the burden of a GFD may be 
unfounded, at least over the short-term (Mustalahti Lohiniemi, Collin, Vuolteenaho, 
Laippala & Mäki, 2002).  They also acknowledge that the improvements in QoL after the 
first year of a GFD may not persist and that a longer follow-up period would be necessary 
to explore this. Furthermore, they have used the PGWB to measure QoL which, as its name 
suggests, is probably more appropriate for assessing ‘psychological well-being’ than QoL 
especially, as it does not contain physical and social items that are accepted core 
dimensions of HRQoL and is loaded more towards affective items.       
Usai et al (2002) carried out a study to evaluate whether HRQoL in adult CD is 
related to severity of illness i.e. number of symptoms at diagnosis; compliance to a GFD 
and the presence of associated diseases.  Compared to healthy controls, participants with 
CD obtained worse scores on all domains of the SF-36.  Compliers (59.1%) who had been 
gluten free for at least 2 years, showed better results than non-compliers.  The lowest 
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scores were achieved by participants with more than six symptoms.  Participants with two 
or more associated diseases (in particular autoimmune thyroid disorders) obtained 
significantly worse scores than participants with only one associated disease.  On the basis 
of their results, the authors suggest that the role of adherence to a GFD on HRQoL 
appears to be more relevant in people with fewer symptoms than in more severe cases, as 
in these cases it is likely that the natural course of the disease is only partially modified by 
a GFD.  In addition, they emphasise that CD in adults is frequently complicated by the 
presence of symptoms not necessarily related to the intestinal pathology and not 
responding to GFD alone.  However, the authors acknowledge that the limited number of 
subjects and the retrospective design of the study do not allow any definitive conclusions 
to be made.  
In a large cross-sectional survey (Ciacci et al, 2003) members of five Italian regional 
coeliac societies who were on a GFD for at least one year completed a partially validated 
questionnaire (SAIC: Self-Administered Inventory for Coeliacs) devised by the authors to 
investigate QoL.  It was found that females adhered to a GFD more strictly than males.  
However, this difference was no longer significant when compliance score was corrected for 
age at diagnosis.  Individuals diagnosed after the age of twenty years had better dietary 
compliance than those diagnosed earlier, and this remained after correcting for gender and 
age.  Self-reported compliance in all participants was 74.1%.  Happiness scores were higher 
in participants diagnosed before 20 years of age.  Although levels of anxiety and depression 
were low, anxiety was related to feeling different and depression to an unsatisfactory sex life.  
The authors concluded that in general, CD was not associated with a low level of self-
perceived quality of life in members of the Italian Coeliac Society.  A major limitation of the 
study is the instrument developed by the authors for which no measure of internal 
consistency is reported.  Using a newly developed measure also makes it difficult to compare 
  24 
the results with previous studies that have used well-established standardised measures of 
HRQoL.  
Johnston, Rodgers and Watson (2004) measured HRQoL in two groups of out-patients 
with different types of CD and a control group.  The SF-36 was completed prospectively by 
all participants who agreed to have a duodenal biopsy as a follow-up to a serological 
screening programme.  Another group of ‘typical’ coeliac patients also completed this 
measure at diagnosis.  The SF-36 was repeated in both groups after one year on a GFD.  The 
authors found no significant differences between the SF-36 scores of the screen detected 
coeliac group and those of healthy controls at baseline and at follow-up.  However, three SF-
36 sub-scales (general health, vitality and role emotional) were significantly lower in 
‘typical’ coeliac patients compared to controls and two of these (general health and vitality) 
improved significantly at one year follow-up compared to the baseline data.  General health 
significantly improved in ‘typical’ coeliac patients but not screen-detected patients after one 
year on a GFD.  However, the authors acknowledge that the small numbers in their study 
may not have been sufficient to detect a significant difference.  
In a large cross-sectional survey Zarkadas et al (2006) evaluated the impact of a GFD 
on members (with biopsy-proven disease) of the Canadian Coeliac Association (CCA).  A 
postal survey was used to measure QoL using the SF-12 and coeliac specific questions 
devised by the authors.  It was found that mean SF-12 scores were similar to normative 
Canadian data, but were significantly lower for females and newly diagnosed participants. 
Ninety percent of participants reported adherence to a GFD.  The authors concluded the QoL 
in adults with CD could be enhanced with early diagnosis, increased availability of GF foods 
and improved food labelling.  Limitations of the study include the lack of a matched control 
group and probable sample selection bias due to targeting only members of the CCA.   
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Casellas et al (2008) recently investigated factors impacting on HRQoL in adults with 
CD in a multicentre study.  Two groups of participants, those controlled with a GFD and 
newly diagnosed individuals on a normal diet, completed two HRQoL questionnaires (the 
GIQLI and EQ).  The results of these measures indicated that the HRQoL of untreated, 
recently diagnosed individuals with CD was significantly impaired on almost all dimensions 
and overall scores compared to the GFD group who had EQ scores that were comparable to 
the general Spanish population.  In addition, female gender, non-adherence to a GFD and 
symptomatic status were significantly associated with poorer HRQoL score.  HRQoL was re-
assessed in recently diagnosed individuals at least six months after starting a GFD and 
GIQLI scores were significantly improved.  The authors concluded that HRQoL improves to 
levels similar to those in the general population in individuals with CD controlled with a 
GFD for at least six months.  However, the number of individuals assessed before and after 
commencing treatment was very small.  The authors acknowledge that another limitation of 
the study is probable selection bias due to only including participants from a hospital 
population.  
Of the nine studies described above, three were prospective in design.  In general the 
results of the studies using the SF-12/36 showed a reduced HRQoL of life in individuals 
living on a GFD.   However, in the Canadian and Swedish (retrospective) studies this 
impoverishment was confined only to females.  In the UK prospective study, scores for 
‘typical’ coeliac patients improved after one year of adhering to a GFD, unlike screen-
detected (asymptomatic) individuals whose scores remained comparable to healthy controls 
before and after starting a GFD.  Similarly, in the Finnish prospective study, individuals with 
symptom-detected disease had poorer PGWBI scores than those with screen-detected CD.  
However, both groups improved after one year of a GFD.  In the Spanish prospective study, 
the authors found that compared to individuals controlled by a GFD, untreated recently 
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diagnosed individuals have impaired HRQoL.  They also found an association between 
female gender and poorer HRQoL. 
 
Studies using self-report instruments of HRQoL and psychological distress  
Fera, Cascio, Angelini, Martini & Guidetti (2003) investigated the prevalence of self-
reported depressive symptoms and HRQoL in adults with CD on a GFD.  Three groups of 
participants: those with CD (on a GFD for at least a year) individuals with diabetes and 
healthy controls, completed the M-SDS, the STAI and SF-36.  The IBQ was only completed 
by the CD group and patients with diabetes.  Amongst those with CD the mean duration of 
GFD was 9.1 ± 8.7 years (range 1-32). It was found that average M-SDS scores were 
significantly higher in the CD group than in healthy controls but there were no differences 
when compared to the participants with diabetes.  On the state scale of the STAI participants  
with CD and those with diabetes had significantly higher scores compared to healthy 
controls.  Duration of GFD was associated with significantly higher depression scores in 
those with CD who had a more recent diagnosis (>1 and ≤ 3 years).  HRQoL was reduced in 
individuals with CD and those with diabetes compared to healthy controls and significantly 
correlated with state anxiety scores.  The IBQ showed a high psychological and somatic 
perception of illness in individuals with CD and those with diabetes and its sub-scales were 
significantly correlated with anxiety.  The authors emphasise that their study found the same 
depression rates amongst individuals with CD and those with diabetes which may indicate 
that depression is a consequence of chronic disease requiring dietary restrictions.  However a 
longitudinal study with a homogeneous sample would be needed to investigate this 
hypothesis further.  
Using the PGWBI and GSRS, Viljamaa and colleagues (2005) investigated dietary 
compliance and QoL after long-term treatment (median 14 years) in those with CD identified 
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by serological screening.  Comparisons were made between symptom detected individuals, 
those who were untreated and healthy controls.  The SF-36 was used to assess HRQoL, but 
was only completed by the screen-detected individuals and then compared to a Finnish 
population sample. GFD adherence rates were high (96% in screen-detected and 93% in 
symptom detected individuals) and were not related to age at diagnosis.  PGWBI total and 
sub-scale scores in screen-detected individuals did not differ from those of either symptom-
detected individuals or non-coeliac controls.  A curious finding was that SF-36, average 
mental health sub-scale scores were significantly better in screen-detected participants than 
in the general population.  Total GSRS scores were lower (non-significant) in screen-
detected individuals than in symptom-detected group and healthy controls, indicating fewer 
symptoms. The authors conclude that QoL in screen-detected individuals was comparable 
with that in symptom detected individuals (Viljamaa Collin, Huhtala, Sievänen, Mäki and 
Kaukinen 2005).  However, the SF-36 a robust and commonly used measure of HRQoL was 
not administered to the latter group, only the PGWBI which arguably is more a measure of 
psychological well-being.  Therefore their conclusions cannot be fully justified.  
 In a national survey (Hauser, Gold, Stein, Caspary & Stallmach, 2006) a set of 
questionnaires including the SF-36 and HADS were posted to members of the German 
Coeliac Society (GCS).  Compared to representative samples from the German population, 
the participants had higher scores for anxiety but not depression on the HADS.  The rate of 
participants with a probable psychiatric disorder was not significantly different from the 
general population.  In all sub-scales of the SF-36 except ‘physical function’ participants 
with CD had a significantly reduced HRQoL than population comparisons.  The authors 
acknowledge some limitations of their study.  Firstly, due to their sample being recruited 
from the GCS they cannot rule out a possible selection bias.  Secondly, there could also be a 
response bias of CD patients with a reduced HRQoL sending back the questionnaires. 
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Nachman et al (2008) prospectively assessed differences in HRQoL and depression 
scores of individuals with CD to assess time-course impact of a GFD.  They used the SF-36, 
the GSRS and BDI at diagnosis and at 3 and 12 months follow-up on treatment.  Newly 
diagnosed individuals with classical symptoms were compared with atypical/silent cases and 
healthy controls. At baseline (diagnosis) both the classical symptom and atypical/silent 
groups had significantly lower SF-36 sub-scale scores compared with healthy controls except 
for ‘Role Emotional’ in the atypical/silent group.  On the BDI compared with controls, both 
groups with CD had significantly higher baseline scores.  On both the BDI and SF-36 
atypical/silent cases faired significantly better than the classical group.  In general, the GSRS 
scores of the two CD groups were significantly worse at baseline compared with controls.  
Compared with atypical/silent cases, those with classical CD revealed significantly higher 
baseline scores for four out of five items.  Treatment (GFD) produced a substantial and rapid 
(3-month) improvement on most outcome measures in individuals with classical and atypical 
disease, but not in silent cases (n=10).  After one year on treatment both CD groups achieved 
comparable final scores on all measures in line with normative scores.  The authors state that 
their study shows that at diagnosis individuals with atypical/silent CD have a significantly 
better HQoL than those with classical symptoms. They acknowledge that a weakness of this 
study is the small number of cases with ‘silent’ disease’ two of whom dropped out at final 
follow-up.  
From the above studies, two out of the three that were retrospective in design found 
that scores for HRQoL were reduced compared to healthy controls/population comparisons, 
whilst the other found that screen-detected individuals with CD were no worse off than 
general population controls. The prospective study found that prior to starting a GFD, 
individuals with classical symptoms had lower HRQoL scores than those with atypical/silent 
disease – both groups having significantly reduced scores compared to healthy controls.  
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After one year on treatment, HRQoL scores improved in both groups in line with normative 
levels.  
In the Italian retrospective study, depression scores were higher in the CD group 
compared to controls.  In the Argentinean prospective study depression scores for both the 
classical and atypical/silent groups were higher than controls prior to starting a GFD, with 
the atypical group having better scores than the classical group.  Both groups improved after 
1 year follow-up on GFD.  In the Italian study, significantly higher state anxiety scores were 
found in individuals with CD compared to controls.  Higher scores for anxiety but not 
depression were found in the German survey.  In the Finish study psychological well-being 
scores in screen-detected individuals did not differ from those in symptom detected 
individuals or non-coeliac controls.  
 
Summary and Discussion 
A total of 21 studies were reviewed and all except one (Hallert et al, 2002) had samples 
biased towards women. As emphasised in the introduction, HRQoL is a multi-dimensional 
concept that has developed from the need to assess the individual’s subjective evaluation of 
the psychosocial impact of disease, including subjective health status and self-reported 
emotional/psychological well-being.  In the reviewed literature, some of the studies aimed to 
assess key elements of HRQoL such as psychological well-being/distress and 
psychopathology in relation to CD and others used generic multi-dimensional measures that 
tapped various aspects of HRQoL such as physical functioning (e.g. physical pain and role 
limitation) and mental health (e.g. emotional vitality and social functioning).   
To a small extent, the literature distinguished between chronic illness generally and 
coeliac disease.  For example, there were 3 studies that used control groups of those with 
other chronic conditions namely, diabetes and chronic persistent hepatitis (CPH).  Results 
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indicated that the perceived disease burden of individuals with diabetes and CD treated for a 
mean of 10 years was similar.  In addition, the same rates of depressive symptoms were 
found amongst those with diabetes and CD (significantly higher than healthy controls) 
leading the authors to conclude that symptoms of depression are a consequence of chronic 
disease that requires dietary restrictions. Compared to individuals with CPH and ‘normal’ 
controls it was found that those with CD had significantly higher rates of self-reported 
depressive symptoms, thus supporting the former theory. 
Overall studies tended to focus on the psychosocial aspects of living with CD itself and 
the specific effects of maintaining a GFD.  Those that looked at the effects of a GFD 
distinguished between individuals who had recently been diagnosed and started a GFD and 
those who had been living on a GFD for a number of years having been diagnosed for some 
time.  For example, results from 3 prospective studies revealed that asymptomatic individuals 
had better HRQoL scores than symptom-detected (classical) individuals at diagnosis. 
However, after one year on a GFD these scores were comparable for both groups. However, 
retrospective studies have found evidence for reduced HRQoL and poor psychological well-
being in individuals treated for 10 & 14 years.  Therefore, longer-term prospective studies 
are needed to explore persistence in improvements on a GFD. 
The retrospective design of the majority of the studies makes them open to risk of 
selection bias and makes it difficult to ascertain cause-and-effect, because of various possible 
confounding factors.  They also rely heavily on the accurate recall of the participants.  
Difficulties when interpreting and comparing the results of the reviewed literature apart from 
the different measures used include differences in: sample populations, country of origin, age 
group, CD type, duration of GFD and adherence rates. Furthermore, some studies were 
mostly descriptive in nature and others employed multivariate logistical techniques. 
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All the studies reviewed used translated, self-report instruments that may bias answers 
to sensitive questions such as dietary compliance.  However, anonymity of the data would 
have minimised such bias.   The most consistently used measure the SF-36 is one of the most 
commonly used, robust instruments for the study of HRQoL.  However, it should be stressed 
that it is a generic tool not specifically designed for the study of CD.  There is a need for 
further long-term prospective studies using larger samples, multivariate analysis and more 
specific standardised HRQoL measures.  Several of the studies focussing on psychological 
distress implied that they measured affective/psychiatric disorder.  However, these studies 
used self-report instruments rather than formal psychiatric interviews, so that no conclusions 
can be drawn from them about the prevalence of psychiatric/affective disorders in people 
with CD. 
In three studies (one prospective) female gender was linked to poor HRQoL scores and 
in another reduced psychological well-being.  A Swedish study later found that women with 
CD adhering to a GFD perceived their disease burden to be worse than men and coped less 
well with the social inconvenience to their daily activities.  
Reduced HRQoL was consistently found in studies using the SF-36 a generic self-
report instrument for assessing HRQoL however, only two were prospective and both these 
had small sample sizes. The presence of self-reported depressive symptoms was also 
invariably found using the M-SDS and one prospective study found evidence for persistence.  
The prevalence of anxiety is less clear cut due to different measures being used in each study.  
Two prospective studies found anxiety before, but not after commencement of a GFD and 
two retrospective studies found high anxiety scores in individuals with CD compared to 
controls.  A further study using the PGWBI found no indications of anxiety.    
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Conclusions 
The findings of this review suggest that in addition to reduced HRQoL, psychological 
distress, especially symptoms of anxiety and depression is commonly found in people with 
CD. Although anxiety can be experienced, the literature suggests that this tends to decrease 
on a GFD.  However, several studies found that depressive symptoms and poor HRQoL 
persisted even in treated individuals.  This may be due to anxiety in people with CD being 
mainly related to the presence of disabling symptoms such as abdominal pain, diarrhoea and 
weight loss that tend to dissipate on starting a GFD thus, reducing the anxiety; whereas 
depressive symptoms might be sustained by the reduction in quality of life (supported by 
several studies) due to dietary restrictions and related changes in social habits and lifestyle, 
perhaps more so in women.    
 
Implications for clinical practice         
In addition to reduced HRQoL, psychological distress, especially symptoms of 
persistent depression, is commonly found in individuals with CD. Depression can be a major 
reason for non-adherence to treatment in people with chronic medical diseases (DiMatteo, 
Lepper & Croghan, 2000).  Therefore, it would seem prudent to screen men and women with 
CD for probable mood disorders so that appropriate psychological support can be provided 
which has been shown to reduce depression and improve GFD adherence (Addolorato, 
Lorenzi, Abenavoli, Leggio, Capristo & Gasbarrini, 2004).    
A better understanding of the psychosocial effects of CD could enhance clinical 
management and ultimately improve the quality of life for adults with the disease.  In 
particular, studies are needed to explore the extent to which clinically significant levels of 
emotional distress are accounted for by lack of psychological help to support individuals 
living on a gluten-free diet. 
References 
Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G (1996).  
Anxiety and depression in adult untreated celiac subjects and in patients affected by 
inflammatory bowel disease: a personality “trait” or a reactive illness? 
Heptogastroenterology, 43: 1513-1517. 
Addolorato G., Capristo E., Ghittoni G., Valeri C., MascianÃ  R., Ancona C., Gasbarrini  
G. (2001). Anxiety but not depression decreases in coeliac patients after one-year 
gluten-free diet: a longitudinal study. Scandinavian Journal of Gastroenterology, 36: 
502-6. 
Addolorato G, De Lorenzi G, Abenavoli L, Leggio L, Capristo E, Gasbarrini G ( 2004).  
Psychological support counselling improves gluten-free diet compliance in coeliac 
patients with affective disorder.  Alimentary Pharmacology & Therapeutics, 20: 777-
82. 
Addolorato G., Leggio L., D'Angelo C., Mirijello A., Ferrulli A., Cardone S., Vonghia 
L., Abenavoli L., Leso V., Nesci A., Piano S., Capristo E. & Gasbarrini G. (2008).  
Affective and psychiatric disorders in celiac disease.  Digestive Diseases, 26: 140-8.  
Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Vonghia L, Cardone 
S, Leso V, Miceli A, Gasbarrini G. (2008). Social phobia in coeliac disease. 
Scandinavian Journal of Gastroenterology, 43: 410-5. 
Barone MV, Caputo I, Ribecco MT, Maglio M, Marzari R, Sblattero D, Troncone R,  
Auricchio S, Esposito C (2007). Humoral immune response to tissue transglutaminase 
is related to epithelial cell proliferation in celiac disease. Gastroenterology, 132 
(4):1245-53. 
 
 
  34 
 Casellas F, Rodrigo L, Vivancos JL, Riestra S, Pantiga C, Baudet JS, Junquera F,  
Diví VP, Abadia C, Papo M, Gelabert J, Malagelada JR. (2008). Factors that impact 
health-related quality of life in adults with celiac disease: a multicenter study. World 
Journal of Gastroenterology, 14: 46-52. 
Catassi C., Rätsch I.M., Fabiani E., Rossini M., Bordicchia F., Candela F., Coppa G.V. &  
Giorgi P.L. (1994).  Coeliac disease in the year 2000: exploring the iceberg. Lancet, 
343: 200-203. 
Ciacci C., Iavarone A., Mazzacca G., De Rosa A. (1998). Depressive symptoms in adult 
  celiac disease. Scandinavian Journal of Gastroenterology, 33: 247-250. 
Ciacci C., Iavarone A., Siniscalchi M., Romano R., De Rosa A. (2002). Psychological  
dimensions of celiac disease: toward an integrated approach. Digestive Diseases & 
Sciences, 47: 2082-7. 
Ciacci C., D'Agate C., De Rosa A., Franzese C., Errichiello S., Gasperi V., Pardi A., 
Quagliata D., Visentini S., Greco L. (2003).  Self-rated quality of life in celiac disease. 
Digestive Diseases and Sciences. 48: 2216-20. 
Coeliac UK. Available at: http://www.coeliac.org.uk/glutenfree_living/  
the_glutenfree_diet/default.asp.  Accessed 12 December 2008. 
Collin, P., Kaukinen, K., Mattila, A., Joukamaa, M. (2008). Psychoneurotic symptoms  
and alexithymia in coeliac disease.  Scandinavian Journal of Gastroenterology, 43: 
1329-1333. 
Cooke W.T. & Smith W.T. (1966). Neurological disorders associated with adult celiac  
disease. Brain, 89: 683-722.  
Cooper BT, Holmes GKT & Kooke WT (1978). Coeliac disease and immunological  
disorders. British Medical Journal, 1: 537-539. 
  35 
 Cranney A, Zarkadas M, Graham ID, Switzer C. (2003).  The Canadian celiac health  
survey - the Ottawa chapter pilot, BMC Gastroenterology, 3: 8.  
De Rosa A., Troncone A., Vacca M., Ciacci C. (2004). Characteristics and quality of  
 illness behavior in celiac disease. Psychosomatics, 45: 336-42. 
Dewar D, Pereira SP, Ciclitira PJ (2004). The pathogenesis of coeliac disease.  
International Journal of Biochemistry and Cell Biology. 2004, 36: 17-24. 
DiMatteo, M.R., Lepper, H. & Croghan, T.W. (2000).  Depression is a risk factor for  
non-compliance with medical treatment.  Meta-analysis of the effect of anxiety and 
depression on patient adherence.  Archives of Internal Medicine, 160: 2101-7. 
Egan L.J., Stevens F.M. & McCarthy C.F. (1996). Celiac disease and T-cell lymphoma.  
New England Journal of Medicine, 335: 1611-1612. 
Feighery C (1999). Fortnightly review: Coeliac disease.  British Medical Journal, 319:  
236 – 239. 
Fera T., Cascio B., Angelini G., Martini S., Guidetti C.S. (2003). Affective disorders and  
quality of life in adult coeliac disease patients on a gluten-free diet.  European Journal 
of Gastroenterology & Hepatology, 15: 1287-92. 
Ferguson A. (1997). Celiac disease, an eminently treatable condition, may be under  
diagnosed in the United States.  American Journal of Gastroenterology, 92: 1252-
1254. 
Fitzpatrick R., Fletcher A., Gore S., Jones D., Spiegelhalter D. & Cox D. (1992). Quality  
of life measures in health care I: applications and issues in assessment. British Medical 
Journal, 305: 1074-1077.  
Goddard C.J.R. & Gillett H.R. (2006). Complications of celiac disease: are all patients at  
risk? Postgraduate Medical Journal, 82: 705-712. 
  36 
 Green P.H.R., Stavropoulos S.N., Panagi S.G., Goldstein S.L., McMahon D.J., Absan H.,   
Neugut A.I. (2001). Characteristics of adult celiac disease in the USA: results of a 
national survey. The American Journal of Gastroenterology, 96: 126-131. 
Guyatt G.H., Feeny D.H., Patrick D.L. (1993). Measuring health-related quality of life.  
Annals of Internal Medicine, 118: 622-629. 
Haboubi N.Y., Taylor S., Jones S. (2006). Coeliac disease and oats: a systematic review.  
Postgraduate Medical Journal, 82: 672-678. 
Hallert C., Grännö C., Grant C., Hultén S., Midhagen G., Ström M., Svensson H.,  
Valdimarsson T., Wickström T. (1998). Quality of life of adult coeliac patients treated 
for 10 years. Scandinavian Journal of Gastroenterology, 33: 933-938. 
Hallert C & Lohiniemi S (1999). Quality of life of celiac patients living on a gluten-free  
diet. Nutrition, 15: 795-797. 
Hallert C, Grännö C, Hultén S, Midhagen G, Ström M, Svensson H, Valdimarsson T.  
(2002). Living with coeliac disease: controlled study of the burden of illness. 
Scandinavian Journal of Gastroenterology, 37: 39-42. 
Häuser W., Gold J., Stein J., Caspary W.F., Stallmach A. (2006). Health-related quality  
of life in adult coeliac disease in Germany: results of a national survey. European 
Journal of Gastroenterology & Hepatology, 18: 747-754 
Häuser W, Gold J, Stallmach A, Caspary WF, Stein J (2007).  Development and  
validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related 
quality of life measure for adult patients with celiac disease.  Journal of Clinical 
Gastroenterology, 41: 157-166. 
Holmes, GKT (1996). Non-malignant complications of coeliac disease.  Acta Paediatrica  
 Suppl, 412: 68-75.   
  37 
 Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, Sloan  
ME, Dixon S & Sanders DS (2007).  Pre-endoscopy serological testing for coeliac 
disease: evaluation of a clinical decision tool. British Medical Journal, 334: 729-734. 
Ivarsson A., Persson L.A., Juto P., Peltonen M., Suhr O. & Hernell O. (1999). High  
prevalence of undiagnosed coeliac disease in adults: a Swedish population-based 
study. Journal of internal medicine, 245: 63-68. 
Johnson S.D., Watson R.G.P., McMillan S.A., Sloan J & Love A.H.G. (1997).  
Prevalence of coeliac disease in Northern Ireland.  Lancet, 350: 1370. 
Johnston SD, Rodgers C, Watson RG. (2004). Quality of life in screen-detected and  
typical coeliac disease and the effect of excluding dietary gluten.  European Journal of 
Gastroenterology & Hepatology, 16: 1281-6. 
Jones R. (2007). Coeliac disease in primary care (editorial).  British Medical Journal,  
334: 704-705. 
Ludvigsson, J.F., Reutfors, J., Ösby, U., Ekbom, A., Montgomery, S.M. (2007). Coeliac  
disease and risk of mood disorders: a general population-based cohort study.  Journal 
of Affective Disorders, 99: 117-126. 
Mäki M. & Collin P. (1997). Coeliac disease.   Lancet, 349: 1755-1759. 
Mustalahti K, Lohiniemi S, Collin P, Vuolteenaho N, Laippala P, Mäki M. (2002).  
Gluten-free diet and quality of life in patients with screen-detected celiac disease. 
Effective Clinical Practice, 5: 105-13. 
 
 
 
 
  38 
 Nachman F, Mauriño E, Vázquez H, Sfoggia C, Gonzalez A, Gonzalez V, Plancer del 
Campo M, Smecuol E, Niveloni S, Sugai E, Mazure R, Cabanne A, Bai JC. (2008). 
Quality of life in celiac disease patients: prospective analysis on the importance of 
clinical severity at diagnosis and the impact of treatment. Digestive and Liver Disease, 
41:15-25. Epub 2008 Jul 3. 
Rewers M. (2005). Epidemiology of celiac disease: what are the prevalence, incidence,  
 and progression of celiac disease? Gastroenterology, 128: 547-551. 
Roos S., Kärner A., Hallert C. (2006). Psychological well-being of adult coeliac patients  
treated for 10 years. Digestive and Liver Disease : Official Journal of the Italian 
Society of Gastroenterology and the Italian Association for the Study of the Liver, 38: 
177-80. 
Rostrom A., Murray J.A. & Kagnoff M.F. (2006).  American Gastroenterological  
Associate (AGA) Institute technical review on the diagnosis and management of celiac 
disease.  Gastroenterology, 131: 1981-2002. 
Sajid M.S., Tonsi A., Baig M.K. (2008). Health-related quality of life measurement.  
International Journal of Health Care Quality Assurance, 21: 365-373. 
Siniscalchi, M.; Iovino, P.; Tortora, R.; Forestiero, S.; Somma, A.; Capuano, L.,  
Franzese, M. D.; Sabbatini, F.; Ciacci, C. 2005.  Fatigue in adult coeliac disease. 
Alimentary Pharmacology & Therapeutics, 22: 489-494. 
Sverker A, Hensing G & Hallert C (2005).  Controlled by food – lived experiences of  
 coeliac disease.  Journal of Human Nutrition & Dietetics, 18: 171-180. 
Usai P., Minerba L., Marini B., Cossu R., Spada S., Carpiniello B., Cuomo R., Boy M.F.  
(2002). Case control study on health-related quality of life in adult coeliac disease.  
Digestive Liver Disease, 34: 547-552. 
  39 
  40 
 
Ventura A., Magazzu G. & Greco L. (1999).  Duration of exposure to gluten and risk for  
autoimmune disorders in patients with celiac disease.  SIGEP study group for 
autoimmune disorders in celiac disease. Gastroenterology, 117: 297-303. 
Viljamaa M., Collin P., Huhtala H., Sievänen H., Mäki M., Kaukinen K. (2005). Is  
coeliac disease screening in risk groups justified? A fourteen-year follow-up with 
special focus on compliance and quality of life.  Alimentary Pharmacology & 
Therapeutics, 22: 317-24. 
West J., Logan R.F.A., Smith C.J., Hubbard R.B. & Card T.R. (2004).  Malignancy and  
mortality in people with coeliac disease: population based cohort study.  British 
Medical Journal, 2004: 329: 716 – 719. 
World Health Organisation Quality of Life Group (1996). “What quality of life?” World  
Health Organisation Quality of Life Assessment, 17: 354-356. 
Zarkadas M., Cranney A., Case S., Molloy M., Switzer C., Graham I.D., Butzner J.D.,  
Rashid M., Warren R.E., Burrows V. (2006). The impact of a gluten-free diet on adults 
with coeliac disease: results of a national survey. Journal of Human Nutrition & 
Dietetics, 19: 41-49. 
  
 
 
 
 
 
 
Living with Coeliac Disease: A Cross-sectional 
Survey of a UK Population. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Word count (excluding abstract, tables, references): 6554 
   
ABSTRACT  
 
Coeliac Disease (CD) is an incurable autoimmune condition managed by a 
therapeutic gluten-free diet for life.  European studies suggest that the chronicity of CD, 
the limitations imposed by the need to follow a permanent restrictive diet and the risk of 
other associated serious diseases can have a negative impact on health-related quality of 
life (HRQoL) and psychological well-being.  However, studies concerning the 
psychosocial effects of CD in the UK population are scarce.  This postal survey explored 
the illness perceptions and self-efficacy beliefs of adults with CD in the UK and reports 
their subjective levels of HRQoL and psychological well-being.  Questionnaires were 
returned by 288 members of Coeliac UK.  In this sample, HRQoL and psychological well-
being were found to be reduced with levels being comparable to those found in previous 
related studies.  Participants with weak beliefs in the serious consequences of CD and 
reduced emotional reactions to the condition had a greater likelihood of having enhanced 
HRQoL, improved psychological well-being and increased self-efficacy. Strong beliefs in 
personal control over the condition and a greater perceived understanding of CD were also 
associated with increased self-efficacy.   The results suggest that perceived self-efficacy 
and illness perceptions could play an important role in informing psychological 
interventions for individuals with CD.  
 
 
Key words: Coeliac Disease; Gluten-free diet; Psychological Well-being; Illness 
perceptions; Self-efficacy; Health Related Quality of Life. 
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 INTRODUCTION 
Coeliac Disease (CD) is a chronic autoimmune disorder in which hypersensitivity to 
gluten causes damage and inflammation to the small intestine in genetically susceptible 
individuals (Fera, Cascio, Angelini, Martini & Guidetti, 2003). Those with an untreated 
condition experience intestinal malabsorption due to partial or total atrophy of the tiny 
finger like projections (villi) on the surface of the small intestine (Jones, 2007). The 
condition is also associated with osteoporosis, and fertility problems in women, type I 
diabetes (Feighery, 2007) and an increased risk of gastrointestinal cancer and non-
Hodgkin’s lymphoma (West, Logan, Smith et al, 2004).  It is estimated that CD may affect 
up to 1 in 100 people in Western European populations, although many individuals remain 
undiagnosed (Hopper et al, 2007).  Diagnosis is usually achieved through a screening 
blood test followed by a biopsy of the small intestine to detect villous atrophy.  CD can 
occur at any age, but in adults the peak incidence is in the fifth decade and females are 
more commonly affected than males (Jones, 2007). 
The condition is incurable but is managed by a therapeutic gluten-free-diet for life.  A 
gluten-free diet (GFD) involves the complete avoidance of all foods made from or 
containing wheat, rye, barley and usually, oats such as bread, pizza, biscuits, cake, pasta 
and cereals. This diet is very successful in managing the symptoms of CD as the removal 
of gluten allows the villi to re-generate therefore leading to the normal absorption of 
nutrients.  A GFD also protects against non-Hodgkin’s lymphoma, corrects anaemia, 
restores normal nutritional balance, and substantially improves quality of life, particularly 
if unpleasant gastrointestinal symptoms have been present (Häuser, Gold, Stallmach, 
Caspary & Stein, 2007). 
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Although the literature on the immunology and physiopathology of CD is now 
extensive (Kagnoff, 2005; Barone et al, 2007) the impact of the condition from the 
individual’s view is less well known.  The chronicity of the condition, the limitations 
imposed by the need to follow a permanent restrictive diet and the risk of other associated 
diseases can have a negative impact on health-related quality of life (HRQoL) (Casellas et 
al, 2008) and psychological well-being (Addolorato et al, 2008). 
It is therefore not surprising that, increasingly the focus of research is turning to the 
psychosocial impact of CD on those with the condition and their families (Fera et al, 2003; 
Hallert, Sandlund & Broqvist, 2003).  Much of this research is concerned with 
psychological well-being and health related quality of life (HRQoL).  European studies 
suggest that depression and lower quality of life affect individuals with CD, and anxiety 
and depression have been identified as major causes of lower levels of adherence to 
treatment recommendations (Addolorato, Stefanini, Capristo, Caputo, Gasbarrini & 
Gasbarrini, 1996) and poor adaptation to the disease (Ciacci, Iavarone, Mazzacca & De 
Rosa 1998).  There is a suggestion from the existing literature that women with CD 
experience poorer quality of life than their male counterparts. A Swedish 10-year follow-
up study (Hallert et al, 1998) for example, found that adult female coeliac patients scored 
significantly lower than the general population on a subjective measure of health, 
specifically within the domains of General Health and Vitality.  A later extension of this 
Swedish study (Hallert et al, 2003) found that women with long-standing CD reported 
worse health-related quality of life than men.   
However, studies on the impact of a gluten-free diet (GFD) on HRQoL have 
produced conflicting results. For example, US-American (Green et al, 2001), Canadian 
(Zarkadas et al, 2006) and Swedish studies (Roos, Karner & Hallert, 2006) report an 
average HRQoL for adult celiac sufferers comparable with the general population; whereas 
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studies conducted in Italy (Fera et al, 2003) Northern Ireland (O’Leary et al, 2002) and 
Germany (Häuser, Gold, Stein, Caspary & Stallmach, 2006) demonstrate a reduced HRQL 
compared with the general population or healthy controls. 
To date, various factors have been identified as being associated with reduced 
HRQoL in adults with CD including younger age at diagnosis, anxiety (Ciacci, Iavarone, 
Siniscalchi, Romano & De Rosa, 2002) being newly diagnosed (Zarkadas et al, 2006) 
latency of diagnosis (Usai et al, 2002) poor adherence to a gluten-free diet (Fera et al, 
2003) and somatic and psychiatric comorbidity (Häuser et al, 2007).   
In a study looking at the emotional impact of CD and coping in adulthood (Ciacci, et  
2002) the authors found that relief was the most intensive feeling after diagnosis.  There 
was a positive correlation between feeling different and sadness, anger and fear.  The 
strongest correlation was found between anger and compliance with a gluten-free diet. 
These authors identified a ‘depressive-anxiety factor’ as the main indicator of 
psychological disturbances in a series of long-treated young adult patients.  In a study of 
100 patients treated for 8 years, Fera and colleagues (2003) found a high rate of affective 
disorders that increased with duration of treatment and suggested a close relationship to 
reduced quality of life a common finding in long-treated adults with CD (Hallert et al, 
1998; Lee & Newman, 2003). 
In a German national survey (Hauser et al, 2006) compared to representative samples 
from the general population, the participants had higher scores for anxiety but not 
depression. The rate of participants with a probable psychiatric disorder was not 
significantly different from the general population.  In a Swedish study (Roos et al, 2006) 
the authors found that compared to a healthy control group, patients with CD showed no 
more signs of anxiety, depressed mood or distress. However, unlike controls women with 
CD showed significantly reduced psychological well-being than males. 
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More research is needed to determine whether affective disorders and reduced quality 
of life are a feature of CD.  At present there is a dearth of studies about the psychosocial 
effects of CD in the UK population. Knowledge of the prevalence of psychological distress 
in the UK coeliac population is important for clinical management, particularly as there is 
evidence from Italy that psychological counselling can improve adherence to a gluten-free 
diet in coeliac patients with affective disorder (Addolorato, Lorenzi, Abenavoli, Leggio, 
Capristo & Gasbarrini, 2004). A better understanding and greater knowledge of the 
psychosocial effects of CD on sufferers could enhance the clinical management of the 
condition and ultimately improve the quality of life for adults with the disease. 
The two important concepts of illness representation (Leventhal, Nerenz & Steele, 
1984; Petrie & Weinman, 1997) and self-efficacy (Bandura, 1977; 1997) feature 
prominently in research concerning responses to and coping with chronic illness.  
However, at present there has been no investigation of these concepts in relation to CD. 
Knowledge of these is important for informing therapeutic interventions, to help in the 
clinical management of the disease.     
The illness representation or self-regulatory model (SRM) is the most widely used in 
the last decade to explain how people interpret current and potential health events or 
threats.  It describes patients as active problem solvers whose health related behaviours are 
based upon, and then regulated or influenced by the representations or personal beliefs they 
generate about illness (Leventhal et al, 1984).   The fundamental premise of the model is 
that people are motivated to regulate or minimise their health-related risk and act to 
decrease health threats in ways consistent with their perceptions of them. Sources of 
knowledge on which perceptions are based include the mass of cultural illness information 
(environmental stimulus), individual personal illness experience (perceptual symptoms) 
and social communication (Leventhal et al, 1984).  The constant interaction of 
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environmental and perceptual stimuli within people’s memory systems explains why 
different people construct different representations and devise different action plans to 
respond to similar medical conditions (Lau-Walker, 2006). 
The SRM emphasises that individuals construct a belief about themselves as well as 
their condition.  To be successful therefore, therapeutic interventions need to take account 
of and use these beliefs.  In other words, not only do individuals contemplate what is 
happening to them and the future consequences of their condition, they also have a well 
established construct of themselves, based on their interpretation of their own experiences.  
This influences what they believe they are, or are not capable of acting upon to respond to 
their current health condition (Lau-Walker, 2006). 
A person’s ‘common sense’ illness representations have been shown to predict 
decisions to comply with medical advice and to cope successfully with chronic illness 
(Moss-Morris, Petrie & Weinman, 1996).  In a study looking at illness representation and 
outcome in irritable bowel syndrome (Rutter & Rutter, 2002) the authors found that the 
reporting of serious perceived consequences was associated with lower quality of life and 
higher scores for anxiety and depression.  Weaker control beliefs were also related to lower 
quality of life and higher depression scores.   
Self-efficacy refers to the same theme as the illness representation model i.e. the 
belief that an individual has a well-established construct of themselves, based on their own 
interpretation of their experiences.  Perceived self-efficacy is concerned with people’s 
beliefs in their capabilities to perform a specific action required to achieve a desired 
outcome.  The original theory was developed by Albert Bandura (1977) in the context of 
cognitive behaviour modification.  He asserts that perceived self-efficacy is not a measure 
of the skills one has, but a belief about what one can do under different sets of conditions 
with whatever skills one possesses.  Bandura (1982) distinguished between two types of 
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expectations: outcome expectation and self-efficacy.  Outcome expectation is the belief 
that certain behaviours will lead to a particular outcome, and self-efficacy reflects the 
belief that one can successfully perform these behaviours to produce the outcome.  Self-
efficacy beliefs determine the initial decision to perform a behaviour, the effort to be 
expended and persistence in the face of adversity.  For example, an individual may believe 
that regular exercise will improve his/her future health (high outcome expectancy) but may 
reject this strategy as they have a low efficacy expectancy (never having been a regular 
exerciser they will not see themselves as able to start regular exercise and will not believe 
they have the ability to sustain it).  Therefore, generic educational material on diet that 
focuses only on improving health outcomes rather than addressing individuals’ confidence 
in being able to sustain the diet is unlikely to effectively strengthen their self-management 
abilities. 
It has been found that a strong sense of personal efficacy is related to better health, 
higher achievement and more social integration (Schwarzer & Fuchs, 1995). In order to 
promote individuals’ self-efficacy for managing a long-term health condition, it is 
important that clear, precise and specific knowledge and competence in relevant skills are 
provided to them to support their own management of their particular condition (Lau-
Walker & Thompson, 2009). In general, people’s self-efficacy beliefs influence the health-
related choices they make, the health related goals they set for themselves and the amount 
of effort they use to reach these goals (Wallston, Rothman & Cherrington, 2007).  For 
example, patients with diabetes who adhere to dietary advice and other self-management 
tasks are more likely to report feeling competent to self-manage their diabetes (e.g. Talbot, 
Nouwen, Gingras, Gosselin & Audet, 1997). Based on this, it was hypothesised that 
adherence to a gluten free diet by individuals with CD would be associated with a strong 
sense of self-efficacy. It was also hypothesised that those participants with favourable 
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illness perceptions would have higher levels of perceived self-efficacy to manage their 
condition.  Although illness perceptions and self-efficacy have been independently 
constructed they have a common theme at their core.  Each posits that individuals’ 
personal constructs of their condition and of their ability to cope with that condition are at 
the basis of effective self-management.  Furthermore, both concepts argue that it is through 
an individual’s accumulated experience, rather than personality, that their actions and 
perceptions are informed.  Both theories acknowledge that individuals interpret the events 
that affect them and construct responses and future outcomes from a rational base that is 
unique to each individual (Lau-Walker, 2004).  In view of the fact that there is 
considerable overlap within the two theoretical concepts it seems likely that there will be a 
relationship between the components of the two models and more specifically that illness 
representations will be predictive of self-efficacy.  
 
This study has three main aims as follows:- 
1. To investigate gender differences in quality of life and sense of well-being in adults 
with CD in the UK 
2. To explore the illness perceptions and self-efficacy beliefs of adults with CD in the 
UK 
3. To explore the relationship between individuals’ personal sense of control or self-
efficacy and perceptions of illness, and their well-being and quality of life. 
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METHOD 
Design and Procedure 
The study design was a cross-sectional postal questionnaire.  Adult members (aged 
18 years and over) of Coeliac UK (the national UK charity supporting people with CD) 
were invited to participate in a questionnaire survey designed to investigate the 
psychological and social effects of living with CD.   The survey was advertised in the 
quarterly Coeliac UK magazine.  The advertisement provided a contact telephone number 
for potential interested participants to ring and leave an address so that the survey pack 
could be sent to them.   Each pack contained an information sheet, consent form, five 
questionnaires and a pre-paid envelope for postal return (a copy of the forms in the pack 
can be found in Appendix 6). Some questionnaire packs were also distributed at local 
Coeliac UK support meetings.  Members of Coeliac UK were chosen as potential 
participants because all members of the Society have been medically diagnosed with CD.  
This was an attempt to ensure that those experiencing symptoms of CD, but who had no 
formal diagnosis were excluded from the study. 
The information sheet detailed what the study was about including: who was taking 
part; the benefits and any risks; the right to withdraw; what would happen to the 
information; support networks if some questions were distressing and what was expected 
of participants.  After reading this, participants were asked for their written consent to take 
part in the study before completing the five questionnaires.  These included a social 
demographic questionnaire, the Perceived Medical Condition Self-Management Scale 
(PMCSMS) (Wallston et al, 2007) the Revised Illness Perception Questionnaire (IPQ-R) 
(Moss-Morris, Weinman, Petrie, Horne, Camerson & Buick, 2002) the General Well-
Being Index (British adaptation of the Psychological General Well-being Schedule) (Hunt 
& McKenna, 1992) and the Celiac Disease Questionnaire (CDQ) – a Health Related 
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Quality of Life index (Häuser et al, 2007). Participants were asked to post back all the 
forms in the pre-paid envelop including the signed consent form.  It was stressed in the 
information sheet that the questionnaires would be treated with complete confidentiality.  
Ethical approval was obtained from the University of Birmingham, School of 
Psychology Research Ethics Committee (see Appendices 4 & 5).  
 
Participants 
The majority of participants were women (80%) and of White British origin (95%).  
Men were significantly older than women (mean difference 8.61; Z= -4.08; P= <0.001).  
Adherence to a gluten free diet (GFD) was high with only 13% of participants reporting 
that they did not adhere all the time.  In general, the number of years since diagnosis 
corresponded with the duration of membership in Coeliac UK.  Over half the sample 
(57%) had received their diagnosis in their forties and fifties.  The majority of participants 
were well educated and had professional occupational status. Full sample characteristics 
are presented in Table 1.    
 
Exclusion Criteria 
Adults experiencing symptoms of CD, but who had no formal diagnosis were 
excluded.  Symptoms of CD can be similar to other gastrointestinal diseases; therefore to 
ensure that the sample contained only those suffering from CD, they were not included 
unless they had a medical diagnosis.  The study focused on adult sufferers; therefore, those 
aged below 18 years were excluded. 
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TABLE 1 Sociodemographic Characteristics of Study Sample (n=284) 
 
Variable Number (%) Mean (SD) Range Median 25th – 75th 
Percentile 
Sex (female)                                                
Age All                                                        
      Male  
      Female                                                  
Duration of membership in Coeliac UK 
      <1-5 yrs                                                 
      6-20 yrs                                                 
       >20 yrs                                                 
Years since diagnosis 
     <1-5 yrs                                                 
     6-20 yrs                                                  
     21-40+ yrs                                              
Age at diagnosis 
     <1-20 yrs                                                
     21-40 yrs                                                
     41-50+ yrs                                              
Adherence to a GFD 
     All of the time                                        
     Most/some of the time                           
Marital status 
     Married/co-habiting                               
     Separated/divorced/widowed                 
     Single (never married)                            
Highest educational level 
     No qualifications                                    
     Secondary School                                   
     Vocational training                                 
     University degree                                   
Occupational status (previous or current) 
     Professional                                            
     Managerial/technical                              
     Non-manual skilled                                
     Manual skilled/partly skilled                  
     Non-skilled/home-maker                        
 
227    (80.0) 
 
 
 
133   (46.8)        
103   (36.3)        
48     (16.9) 
                          
127  (44.7)         
103  (36.3)         
53    (18.6) 
                          
34   (12.1)          
85   (30.1)          
163 (57.8) 
                          
246 (86.6)          
37   (13.4) 
 
210 (74.0) 
36   (12.8)          
36   (12.8) 
                          
36    (12.8)         
63    (22.3) 
67    (23.6)        
116  (40.8) 
                          
137  (48.9)         
71    (25.4) 
21    (7.4)           
24    (9.0)   
27    (9.7) 
 
 
54.0 (14.6) 
61.0 (13.6)   
52.3 (14.4)      
 
 
19-85 
23-85 
19-84 
 
 
56 
63 
54 
 
44-65 
53-70 
43-63 
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Measures 
The social demographic questionnaire contained items related to participants’ age, 
sex, ethnicity, educational level, occupational and marital status, age at diagnosis and 
adherence to a gluten-free diet (see Appendix 6).  
 
Perceived Medical Condition Self-Management Scale (PMCSMS) 
A Coeliac Disease-specific adaptation of the Perceived Medical Condition Self-
Management Scale (PMCSMS) was used to assess the degree to which the participants felt 
competent or self-efficacious in managing their CD.  The PMCSMS is an 8-item measure 
based upon the Perceived Health Competence Scale (Smith, Wallston, & Smith, 1995).  It 
was developed as a template that could be made disease-specific and used with any 
medical condition requiring self-management. It has been successfully adapted for use with 
patients with diabetes (type 1 and type 2) and was found to be a reliable and valid measure 
(Wallston et al, 2007).  Responses are rated on a 5-point Likert scale from ‘strongly 
disagree’ to ‘strongly agree’. Higher scores indicate stronger perceptions of self-efficacy.   
 
The Revised Illness Perception Questionnaire (IPQ-R) 
The original Illness Perception Questionnaire (Weinman, Petrie, Moss-Morris & 
Horne, 1996) was developed to provide a quantitative assessment of the five components 
(identity, consequences, timeline, control/cure and cause) of illness representation in 
Leventhal’s Self-Regulatory Model (Leventhal et al, 1984; 1997).  Central to this model 
are the representations (or illness cognitions) that patients have about their illness.  The 
illness representation gives personal meaning to symptoms and it is argued acts as a 
framework for guiding coping efforts.  The revised version (IPQ-R) includes a new 
subscale relating to emotional representations and divides control beliefs into personal 
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attempts to control illness and control of illness by treatment.  It has demonstrated sound 
reliability, discriminant and predictive validity (Moss-Morris et al, 2002).  The illness 
identity subscale measures the number of commonly experienced symptoms such as upset 
stomach that individuals associate with their illness. The consequences subscale measures 
individuals’ beliefs about the seriousness of their condition.  The timeline scale is divided 
into an acute/chronic subscale and a cyclical dimension that measures whether individuals 
view their illness as variable over time.  The control subscale is divided into personal 
control, that refers to beliefs about one’s own ability to control symptoms and treatment 
control that refers to beliefs regarding treatment (or diet) as an effective way of controlling 
the condition. The illness coherence dimension assesses the degree to which patients feel 
they have a coherent understanding of their illness.  The final causal items can be divided 
into four main subscales: psychological causes such as stress and overwork, risk 
attributions such as diet and heredity, causes related to immunity such as a virus and 
chance attributions such as an accident or bad luck.  
 
General Well-being Index (GWBI) 
The Psychological General Well-Being Index originally developed in the US by 
Harold Dupuy (1984) was adapted for use in Britain by Hunt & McKenna (1992) and 
renamed the General Well-Being Index (GWBI).  This instrument assesses emotional well-
being in individuals whose illnesses are not so much physically incapacitating as 
psychologically distressing such as epilepsy, diabetes and it is argued CD.  It provides a 
self-report of intrapersonal affective states that reflect subjective well-being or distress.  
The index consists of questions that cover six affective states: anxiety, depressed mood, 
feelings of positive well-being, self-control, general health and vitality.  The adapted 
measure has been shown to have good psychometric properties while being short, easy to 
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use and acceptable to participants (Hunt & McKenna, 1992). Responses are rated on a 5-
point Likert scale from ‘strongly disagree’ to ‘strongly agree’. The approach adopted in 
this study was to score the items so that higher scores indicated better psychological well-
being. 
 
The Coeliac Disease Questionnaire (CDQ) 
The Coeliac Disease Questionnaire (CDQ) is a reliable and valid disease specific 
instrument for measuring health-related quality of life in adult patients with CD (Hauser et 
al, 2007).  Recently developed in Germany the index has been translated into English.  The 
CDQ comprises four subscales: gastrointestinal symptoms, emotional well-being, social 
restrictions and disease-related worries.  Responses are rated on a 7-point scale from 
‘strongly disagree’ to ‘strongly agree’. High scores indicate a good HRQoL.   
 
Data Analysis 
The data were analysed using the Statistical Package for the Social Sciences (SPSS 
15 for Windows).  
Reliability analyses were carried out on the four questionnaires using Cronbach’s 
alpha (see Table 2 overleaf). These indicated a high level of internal consistency for all the 
measures except four subscales belonging to the IPQ-R, namely: Timeline (acute/chronic); 
Treatment Control; Risk and Immunity.  These items were removed from subsequent 
analyses.   
The Kolmogorov-Smirnov test showed that most variables were not normally 
distributed, therefore non-parametric analyses were chosen (see Appendix 7). However, to  
allow comparisons with the results of other studies both medians and means are presented.  
Preliminary descriptive and univariate procedures were employed before bivariate tests of 
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association were carried out.  Comparisons between variables were performed using the 
Mann-Whitney U or Fisher tests as appropriate.  Binary logistic regression methods were 
employed to investigate the predictive strength of illness perceptions and other factors.   
 
TABLE 2 Reliability coefficients for subscales of all measures 
  
 
Measure and 
Sub-scale 
Number of 
items 
Cronbach’s 
alpha 
PMCSMS 
      Total Scale                                 
 
IPQ-R 
     Identity                                        
     Timeline (acute/chronic)             
     Consequences                             
     Personal control                          
     Treatment control  
     Illness coherence                         
     Timeline (cyclical)                     
     Emotional representations           
     Psychological causes                   
     Risk                                             
     Immunity                                     
 
GWBI 
     Positive well-being                      
     General health                             
     Depressed mood                          
     Anxiety                                        
     Self-control                                 
     Vitality                                        
 
CDQ 
     Gastrointestinal symptoms          
     Emotional well-being                  
     Social restrictions                        
     Disease related worries               
 
8 
 
 
14 
6 
6            
6            
5            
5           
4            
6            
6            
6            
3 
 
 
4            
3            
3            
5            
3            
4 
 
            
7            
7           
7            
7            
 
0.92 
 
                
0.80         
0.51*       
0.79         
0.81         
0.51*       
0.90         
0.92         
0.88         
0.87         
0.67*       
0.42* 
 
 
0.86         
0.86         
0.91         
0.85         
0.88         
0.87 
 
                
0.82         
0.91         
0.85         
0.81      
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 The dependent variables psychological well-being, HRQoL and self-efficacy were 
split at the median to create two equal groups of high scorers and lower scorers.  Up to 
25% of missing items on the PMCSMS, IPQ-R, GWBI and CDQ were replaced by the 
median of the items of the respective sub-scale.  If more than 25% of the items of a 
subscale were missing the respective measure was excluded from further analysis.   
 
RESULTS 
Two hundred and eighty eight out of 433 (66%) questionnaires were received back 
from participating members of Coeliac UK.  Four datasets had to be excluded as they were 
not accompanied by consent forms.  A number of questionnaires were excluded as there 
were more than 25% missing items as follows:- GWBI 10, CDQ 8, IPQ-R 6 and PMCSM 
4.  In total, 14 participants were excluded from the main analyses. 
 
Self-Efficacy 
Table 3 shows descriptive data for the PMCSMS for adherence group and sex and the 
differences between each group. The mean scores for the total sample show a relatively 
high level of perceived self-efficacy.   There was a significant difference in scores between 
the adherence groups.  As predicted, those in the lower group had weaker perceptions of 
their own self-efficacy to manage their CD (Z= -2.0; P=0.04). Conversely, those in the 
higher adherence group had stronger beliefs in their ability to manage their condition.   
There was no difference in the level of perceived self-efficacy to manage their Coeliac 
Disease between men (mean= 32.2) and women (mean= 31.6).   
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TABLE 3 Perceived Self-Efficacy between Adherence Group and Men and Women 
 PMCSMS        Total                                       Lower                                    High           
                       Sample (n=274)                    Adherence  (n=37)              Adherence  (n=237) 
      Mean (SD)  Median (Range)      Mean (SD)  Median (Range)      Mean (SD)  Median (Range) 
        31.7 (5.9)        32 (14-40)           29.2  (7.2)      32 (15-39)            32.1*(5.6)     32 (14-40) 
                                                                    Females  (n=224)                       Males (n=56) 
 PMCSMS                                      Mean (SD)  Median (Range)       Mean (SD)  Median (Range) 
                                                          31.6 (5.9)      32 (14-40)               32.2 (5.7)     32 (14-40) 
*Z= -2.0; P=0.04 
 
 
Psychological Well-being                           
Table 4 (below) shows descriptive data for the General Well-being Index (GWBI) for 
males and females and the differences between the two groups. The distribution of scores 
for the whole sample (not shown) ranged from 29 to 110 with a mean of 79.0 (s.d. 15.4) 
out of a possible top score of 110.  Men tended to score slightly higher than women 
indicating better psychological well-being.  These differences were significant for the total 
score and the following subscales: Anxiety, Depressed Mood and Self-Control.  There was 
no significance in GWBI scores between adherence groups (Z= -0.30; P=0.76). 
 
TABLE 4  Levels of Psychological Well-being between Men and Women  
   GWBI                      Means (standard deviations) and Medians (ranges) 
 Subscale                           Females (n=219)                  Males (n=55)               Difference test 
Anxiety                           17.0 (4.0)    17 (6-25)       19.0 (3.9)    19 (10-25)       Z= -3.1; P=0.002* 
Depressed Mood             11.0 (2.7)    12 (5-15)       12.2 (2.5)    12 (5-15)         Z= -3.0; P=0.002* 
Positive well-being         14.4 (3.1)    15 (5-20)       15.3 (2.7)    16 (8-20)         Z= -1.7; P=0.08 
Self-control                     12.0 (2.3)    12 (5-15)       13.0 (2.0)    13 (8-15)         Z= -2.9; P=0003* 
General Health                10.7 (2.8)    11 (3-15)       11.2 (2.9)    12 (4-15)         Z= -1.3; P=0.19 
Vitality                            12.5 (3.3)    12 (4-20)       13.0 (3.4)    13 (5-19)         Z= -0.9; P=0.36 
Total Score                      76.9 (15.4)  78 (29-110)   83.0 (14.7)  84 (48-108)     Z= -2.5; P=0.01* 
*= significant difference 
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Health Related Quality of Life (HRQoL) 
Table 5 (below) shows the mean and median scores for the Coeliac Disease 
Questionnaire (CDQ) for men and women and the differences between them.  The 
distribution of scores for the whole sample ranged from 61 to 194 with a mean of 152.2 
(s.d. 26.4) out of a possible top score of 196 (not shown) reflecting reduced HRQoL. 
Reduced HRQoL was defined by scores ≤ 10% percentile of the total CDQ score which 
was 10% of the sample.  Men tended to score slightly higher on the CDQ than women, but 
the differences were only significant for the total scores and two sub-scales: Emotion and 
Social.  There was no significant difference in CDQ total score and adherence group (Z= -
1.25; P=0.20). 
 
TABLE 5 Levels of HRQoL between Men and Women  
  
  CDQ                           Means (standard deviations) and Medians (ranges) 
Subscale                            Females (n=219)                   Males (n=55)              Difference test 
Emotion                     33.4 (8.2)     37 (12-49)          36.0  (8.1)     37 (12-49)     Z= -1.9; P=0.04* 
Social                         40.2 (8.5)     46 (11-49)          42.0  (9.6)     46 (11-49)     Z= -2.0; P=0.04* 
Worries                      39.3 (8.1)      41(12-49)          40.6  (8.6)     43 (9-49)       Z= -1.5; P=0.12        
Gastrointestinal          38.0 (7.4)      34 (7-49)           39.4  (7.0)     41 (24-49)     Z= -1.1; P=0.26 
Total Score               150.9 (26.0)  156 (64-194)    157.7  (27.9)  164 (61-194)   Z= -2.1: P=0.03* 
*= significant difference 
 
Illness Perceptions 
Mean scores for consequences (3.5, s.d. 0.82), personal control (4.3, s.d. 0.67) and 
illness coherence (4.2, s.d. 0.82) were high, reflecting a coherent understanding of CD, 
strong perceptions of personal ability to control it and strong beliefs about the serious 
consequences of CD.  Participants did not attribute many symptoms to their CD, reflecting 
a low disease identity (mean 3.3, s.d.2.94). The most important cause identified by 
participants was genetic risk with over half (52.2%) attributing this to the development of 
their condition.  Table 6 shows the mean and median scores for each of the included IPQ-R 
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subscales for men and women and differences between them. The results indicate that 
women had a significantly higher emotional response to their condition than men.  Women 
also had significantly stronger beliefs that their CD was caused by psychological factors 
such as stress and mental attitude; however, there were no gender differences on the other 
dimensions.    
 
TABLE 6 Mean and Median Scores for Illness Perceptions 
 
  IPQ-R                             Means (standard deviations) and Medians (ranges) 
Subscale                                 Females (n=219)                Males (n=55)               Difference test 
Identity 
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional responses 
Psychological causes 
3.5 (3.02) 
3.5 (0.82) 
4.3 (0.62) 
4.2 (0.79) 
2.3 (1.10) 
2.6 (0.96) 
2.0 (0.88) 
3.0  (1-12) 
3.6 (1.3-4.8) 
4.5 (2.1-5.0) 
4.4 (1.8-5.0) 
2.0 (1.0-5.0) 
2.5 (1.0-5.0) 
2.0 (1.0-5.0) 
2.9 (2.58) 
3.5 (0.80) 
4.2 (0.84) 
4.2 (0.95) 
2.0 (0.99) 
2.2 (0.98) 
1.7 (0.74) 
3.0  (1-12) 
3.6 (1.6-5.0) 
4.3 (1.0-5.0) 
5.6 (1.0-5.0) 
2.0 (1.0-4.5) 
2.0 (1.0-5.0) 
1.5 (1.0-3.6) 
Z= -0.8; P=0.40 
Z= -0.2; P=0.83 
Z= -0.4; P=0.68 
Z= -0.1; P=0.90 
Z= -1.4; P=0.14 
Z= -2.7; P=0.005* 
Z= -2.0; P=0.04* 
*= significant difference 
 
 
Associations Between Illness Perceptions and Distress 
Table 7 shows Spearman’s R correlations between illness perceptions, age and self 
efficacy, measures of well-being and HRQoL for the whole sample. The majority of the 
coefficients are modest, lying between 0.40 - 0.65.  Those lying between 0.19 – 0.39 are 
considered low (Cohen & Holliday, 1982).  The lower the disease identity of participants 
the higher their self-efficacy, HRQoL and general well-being scores were.  The weaker the 
beliefs of participants in the severity of their CD, the higher their self-efficacy, HRQoL 
and psychological well-being scores were.  Stronger perceptions of personal control over 
the condition and a clearer understanding of CD were also associated with increased self-
efficacy and improved HRQoL.  The weaker participants’ beliefs that CD was variable 
over time and the lower their emotional responses were to CD the higher their self-
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efficacy, HRQoL and psychological well-being scores were.   Total scores for the CDQ 
and GWBI were also strongly correlated (Spearman’s Rho 0.76, P=0.01). 
 
  TABLE 7 Correlations (Spearman’s R) between Illness Perceptions and Outcome Measures  
Total Scores n= 274 
                                                PMCSMS                CDQ                    GWBI 
Age 
Identity 
Consequences 
Personal Control 
Illness Coherence 
Timeline cyclical 
Emotional representations 
 0.19** 
-0.37** 
-0.43** 
 0.46** 
 0.56** 
-0.49** 
-0.60**  
 0.24** 
-0.57** 
-0.55** 
 0.22** 
 0.42** 
-0.54** 
-0.65** 
 0.24** 
-0.44** 
-0.32** 
 0.14* 
 0.32** 
-0.49** 
-0.53**  
   *p = 0.01, **p ≤0.001 (based on the Bonferroni correction test, P values ≤ 0.002 are                       
                                                                                                              significant) 
 
Predicting General Well-being, HRQoL and Self-Efficacy 
The results of binary logistic regression analyses to investigate predictors of general 
well-being, HRQoL and self-efficacy are presented in tables 8-10.  Reduced scores on 
Timeline cyclical, Emotional representations, Consequences and older age led to a correct 
classification of an enhanced general well-being in 74% of the sample.  This means that the 
lower the scores for Timeline cyclical, Emotional representations and Consequences the 
more likely it was that participants had higher general well-being scores. In addition the 
older participants were, the more likely they were to have a higher general well-being 
score.   Low scores on Consequences, Illness coherence, Emotional representations and 
Identity led to a correct classification of better HRQoL in 79% of the sample.  This means 
that the lower the scores for Consequences, Illness coherence, Emotional representations 
and Identity the more likely for participants to have a higher HRQoL.  In the self-efficacy 
analysis sex was not entered as no univariate difference had been found (stated previously).  
Lower scores for Consequences and Emotional representations were associated with higher 
self-efficacy scores measured by the PMCSMS as were strong beliefs in Personal control 
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and Illness Coherence (clarity of understanding of CD).  The correct classification rate for 
this model was 78%.   The independent variables Consequences and Emotional 
representations were both predictive of all three outcome measures, general well-being, 
HRQoL and self-efficacy. 
 
 
 
TABLE 8  
Logistic regression analysis of Illness Perceptions predicting increased general well-
being (GWBI) 
 Independent                                  Odds 
   Variables                                    Ratio               95% CI                B               P-value 
Age  
Sex (Male) 
Identity 
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional representations   
1.03 
1.16 
0.91 
0.94 
1.01 
1.02 
0.82 
0.89 
1.00-1.05      
0.53-2.54 
0.80-1.03 
0.87-1.00 
0.93-1.09 
0.93-1.12 
0.74-0.90 
0.83-0.96 
 0.31 
 0.15 
-0.08 
-0.06 
 0.01 
 0.02 
-0.19 
-0.11 
0.007 
   0.69 
   0.16 
   0.05 
   0.78 
   0.63 
   0.000 
 0.002  
      
      
 
    
      
     TABLE 9  
     Logistic regression analysis of Illness Perceptions predicting increased HRQoL (CDQ) 
 Independent                                  Odds 
   Variables                                    Ratio               95% CI                B               P-value 
Age   
Sex (Male) 
Identity 
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional representations   
1.01 
1.31  
0.82 
0.86 
1.05 
1.12 
0.92 
0.87 
0.99-1.03 
0.56-3.07 
0.71-0.94 
0.79-0.94 
0.95-1.15 
1.00-1.24 
0.83-1.02 
0.81-0.94 
 0.01 
 0.27 
-0.19 
-0.14 
 0.05 
 0.11 
-0.07 
-0.13 
0.29 
0.52 
 0.005   
 0.001 
0.28 
0.03 
0.14 
  0.001 
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TABLE 10   
Logistic regression analysis of Illness Perceptions predicting increased Self-efficacy 
(PMCSMS) 
 Independent                                  Odds 
   Variables                                    Ratio               95% CI                B               P-value 
Age   
Identity 
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional representations   
1.02 
1.02 
0.90 
1.14 
1.31 
0.91 
0.90 
0.99-1.04 
0.89-1.16 
0.83-0.98 
1.04-1.26 
1.17-1.48 
0.82-1.00 
0.83-0.96 
 0.02 
 0.02 
-0.10 
 0.13 
 0.27 
-0.09 
-0.10 
0.06 
0.77 
0.01 
  0.005 
  0.000 
0.06 
  0.005 
 
 
The internal validity of the models was good except for self-efficacy.  In the omnibus 
test the coefficients for all three models were significant (P= <0.0001).  The levels of 
significance in the Hosmer-Lemeshov (Goodness of fit) test of the models was 0.97 for 
well-being, 0.42 for HRQoL and 0.05 for self-efficacy - the latter being equal to the 
predefined P-value of 0.05 and therefore indicating a less reliable model.  
Predictors of GFD adherence        
 Table 11 shows the results of a binary logistic regression analysis to predict high 
adherence to a gluten-free diet (GFD). Sex was not entered as there was no evidence of a 
univariate effect (χ2=1.162, P=0.38 Fisher’s Exact).  The most predictive independent 
variables were older age, strong beliefs in the serious consequences and weak beliefs in the 
cyclical nature of CD (or conversely beliefs in the chronicity of the condition).  This means 
that the older participants were and the stronger their beliefs in the seriousness of CD the 
more likely they were to stick to a GFD.  Furthermore, the weaker participants’ beliefs in 
the cyclical nature of CD the more likely they were to adhere to a GFD.  The correct 
classification rate for the model was 86%.  None of the outcome measures, self-efficacy, 
general well-being and HRQoL were strong predictors of high adherence.   
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The internal validity of this model was good.  In the omnibus test the coefficients 
were significant (P= <0.0001) and the significance level in the Hosmer-Lemeshov 
(Goodness of fit) test was 0.86, above the predefined P-value of 0.05, thus confirming 
goodness of fit.   
 
      
     TABLE 11  Logistic regression analysis of factors predicting high adherence to a GFD 
 
 Independent                                  Odds 
   Variables                                    Ratio               95% CI                B               P-value 
Age 
PMCSMS 
GBWI 
CDQ  
Identity  
Consequences 
Personal control 
Illness coherence 
Timeline cyclical 
Emotional representations       
1.04 
1.07 
0.97 
0.99 
0.96 
1.15 
1.08 
1.01 
0.87 
0.94 
1.01-1.07 
0.97-1.17 
0.93-1.02 
0.96-1.02 
0.81-1.13 
1.03-1.28 
0.96-1.20 
0.90-1.13 
0.77-0.98 
0.85-1.05 
 0.04 
 0.07   
-0.03 
-0.01 
-0.03 
 0.14 
 0.07 
 0.01 
-0.14 
-0.05 
0.002 
0.14 
0.17 
0.54 
0.65 
  0.009 
0.16 
0.83 
0.02 
0.31 
   
 
 
DISCUSSION 
This study investigated the psychosocial impact of CD on a UK adult population in 
terms of health-related quality of life and psychological well-being. It is also the first to 
investigate the illness perceptions of individuals with CD.  Previous European studies have 
indicated that depression and lower quality of life affect individuals with CD, and anxiety 
and depression are major causes of lower levels of adherence to treatment 
recommendations (Addolorato et al, 1996;  Ciacci et al, 1998).  There is also a suggestion 
from some studies that women with CD experience poorer quality of life than their male 
counterparts (Hallert et al, 2003). 
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HRQoL, Psychological Well-being and Self-Efficacy 
The results for HRQoL are in line with previous research which indicates that lower 
quality of life affects individuals with CD.  The mean and total distribution of scores for 
the CDQ were comparable with those found in the German Coeliac Society population by 
the authors of the instrument (Häuser et al, 2007).  In this German study to validate the 
CDQ the mean score for participants (n=516) who belonged to the German Coeliac Society 
was 151.1 (s.d. 25.2).  Reduced HRQoL was defined by scores ≤ 10% percentile of the 
total CDQ score which was 11% of the sample.  There were significant differences 
between men and women for all sub-scales, reflecting better health related quality of life 
for men. In the current UK population, the univariate analyses showed that men had higher 
scores than women on the total scale and two subscales, Emotion and Social.  This 
indicates that women were more emotionally affected by their CD than men and found the 
condition more socially restrictive.  However, it could not be demonstrated by multivariate 
analysis that there was an association between male gender and increased HRQoL. 
For psychological well-being the results were similar in that GWBI scores indicated a 
reduced overall level of psychological well-being.  The mean GWBI of this CD population 
was slightly lower compared to individuals with long-term health problems drawn from a 
UK primary care population and considerably lower when compared to a healthy sub-set 
drawn from the same sample. In this UK sample drawn from a general practice population, 
the distribution of GWBI scores ranged from 29 to 109 with a mean of 82.2 (s.d. 14.6).  
Forty five percent of patients had a limiting long-term illness, health problem or handicap 
(Hopton, Hunt, Shiels & Smith, 1995).  In a healthy sub-group of this sample i.e. those 
with no long-standing illness and absence of anxiety and depression, GWBI scores ranged 
from 54 to 109 with a mean of 94.0 (s.d. 10.9).   In the CD sample, there were also slight 
differences between the mean scores of men and women on this measure for total score, 
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and the subscales of anxiety, depressed mood and self-control, with men having a better 
outcome.  Once again however, gender difference was not demonstrated in the multivariate 
analysis. 
The mean PMCSMS scores showed a relatively high level of perceived self-efficacy 
in this CD population meaning that individuals generally felt confident with managing 
their condition.  Those in the lower adherence group had significantly reduced self-efficacy 
compared with those in the high adherence group.  This is in line with early diabetes 
research that found patients adhering to dietary advice were more likely to report feeling 
competent to self-manage their diabetes (Talbot et al, 1997).  However, the PMCSMS was 
not found to predict adherence in the multivariate analysis.  Furthermore, no significant 
difference was found between the scores of men and women unlike the findings in a recent 
study of people with Diabetes where men scored higher than women (Wallston et al, 
2007).  In this study 398 participants with diabetes completed the PMCSM adapted for 
Diabetes namely, the Perceived Diabetes Self-Management Scale (PDSMS).  It was found 
that males scored significantly higher (mean 29.7) than women (mean 28.3).  These self-
efficacy scores for men and women with Diabetes are slightly lower compared to those of 
the CD participants, indicating reduced perceived self-efficacy in the former group 
(Wallston et al, 2007). 
 
Illness Perceptions 
In general the participants reported a coherent understanding of their condition with 
strong perceptions of their personal ability to control it and strong beliefs about the serious 
consequences of CD. Few differences in illness perceptions were identified between men 
and women. The finding that women were more likely to respond more emotionally to 
their CD than men may be a reflection of different ways of coping between men and 
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women (Hallert et al, 2002).  Women also believed more strongly than men that 
psychological causes such as stress had some bearing on the development of their 
condition. Again, this is perhaps a reflection of differences in western society at large in 
which women tend to report more psychological symptoms than men (Wittchen, 2002).  
There were associations between weak identity perceptions and increased HRQoL 
and enhanced general well-being.  Weak beliefs in the serious consequences of CD 
increased the likelihood of increased self-efficacy and HRQoL.  Strong perceived personal 
control increased the probability of a higher self-efficacy score.  Strong perceived illness 
coherence tended to increase the likelihood of better self-efficacy and HRQoL.  A reduced 
emotional response to CD and weak beliefs that the condition was cyclical in nature 
increased the probability of better self-efficacy, good HRQoL and enhanced psychological 
well-being. At present there exist no similar studies investigating the illness perceptions of 
individuals with CD so that comparisons cannot be made.  However, in a study focusing on 
illness representations and outcomes in irritable bowel syndrome (Rutter & Rutter, 2002) 
the authors found similarly that the reporting of serious perceived consequences was 
associated with reduced quality of life and poorer scores for anxiety and depression.   The 
high correlation between CDQ and GWBI scores suggested a close relationship between 
psychological well-being and HRQoL. 
 
Predictors of Psychological Well-being, HRQoL, Self-efficacy and Adherence 
In the binary logistic analyses, the most consistent predictors of all three outcome 
measures were consequences and emotional responses.  Weaker beliefs in the serious 
consequences of CD and reduced emotional responses were more likely to be associated 
with better scores.  The levels of reliability for each model were satisfactory with the 
psychological well-being model showing particularly high reliability. Older age and 
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weaker beliefs in the cyclical nature of CD were more likely to predict enhanced 
psychological well-being.  However, men were significantly older than women in this 
sample meaning that the finding for older age could be caused by older men who had 
higher total scores on the GWBI.  This needs further investigation in subsequent studies.  
A weaker CD identity was more likely to be associated with an improved HRQoL.  Greater 
perceived illness coherence also increased the likelihood of a better HRQoL and higher 
self-efficacy.  Stronger beliefs in personal control were associated with increased self-
efficacy. 
The adherence rate was high with 87% of participants reporting that they stuck to a 
GFD all of the time, the remaining 13% reported that they adhered most or some of the 
time.  The small numbers of low compliers make the analysis of adherence less robust. The 
most significant likely predictors of higher adherence were: older age, stronger beliefs in 
the serious consequences of CD and weaker beliefs in the cyclical nature of the condition. 
Eighty eight percent of the sample had been over the age of 20 when diagnosed and it can 
be speculated from the data that the majority of these participants had been adhering to a 
GFD for some time.  However, it was not proven that adherence was related to time since 
diagnosis.  Nevertheless, the study is in line with Italian research (Fera et al, 2003) that 
showed that adherence to a GFD was related to length of diagnosis with individuals 
diagnosed after the age of 20 years having a better adherence rate than those diagnosed 
earlier.  This is an area for further investigation. Although strong beliefs in serious 
consequences was a likely predictor of adherence, results reported in the paragraph above 
indicated that weaker beliefs in serious consequences increased the likelihood of enhanced 
psychological well-being, HRQoL and Self-efficacy.  However, there was no evidence in 
this study to suggest that those in the high adherence group had poorer scores than the low 
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adherence group on any of these outcome measures.  This interaction effect needs further 
investigation using multivariate techniques.  
 
Limitations of the Study 
Some limitations of the study should be born in mind. For example, the participants 
were recruited from adult members of Coeliac UK leading to a possible selection bias.  In a 
German study of patients with inflammatory bowel disease, membership of a self-help 
organization was predictive of reduced life satisfaction (Janke, Klump, Gregor & Häuser, 
2005).  However, there are no comparative data available between individuals with CD 
with and without membership of Coeliac UK.  It is possible that there is a further response 
bias of individuals with reduced psychological well-being and HRQoL returning the 
questionnaires.  Therefore, it seems unlikely that the findings of the study are 
representative of the UK general population of people with coeliac disease.  Conversely 
this group of individuals is the only available large UK sample studied to date.  The sample 
was predominately white Caucasian, of high educational level and biased towards women 
(although CD tends to affect more women than men).  Individuals with a higher level of 
education are more likely to hold beliefs that are compatible with scientific and medical 
approaches (Bowling, 1989). Therefore, the results of this study may not generalize to 
people with CD of lower educational level or ethnic groups whose beliefs about CD and 
illness perceptions may differ.   
The cross-sectional nature of this study should also be considered, since this means 
that the results show only associations between variables and prohibit conclusions being 
drawn about causality.   The inclusion of a control group or healthy non-CD group would 
have facilitated the interpretation of scores for HRQoL and psychological well-being by 
providing normative data.  It should also be mentioned that the data are self-reported which 
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may bias the answers to sensitive questions such as dietary compliance.  However, 
anonymity of the data was maintained to help minimize this potential bias. 
 
CONCLUSIONS 
Amongst adult members of Coeliac UK there was evidence of reduced HRQoL and 
decreased psychological well-being.  The gender differences in quality of life found in 
previous research were not repeated in the multivariate analyses used in this study.  More 
research is needed in the UK Coeliac Disease population using robust methodologies such 
as case control or longitudinal studies to investigate this potential difference further.   
Further investigation is also required into possible differences in quality of life and 
well-being between those who adhere to a GFD and those who do not.  Self-efficacy and 
illness perceptions appeared to be influential factors in this study and could play a role in 
informing psycho-education for individuals who might benefit from therapeutic 
intervention to improve GFD adherence and enhance psychological well-being.  More 
information is needed on the link between self-efficacy, illness perceptions and adherence 
to a GFD.  Further knowledge of these factors is important for informing therapeutic 
interventions, to help in the clinical management of Coeliac Disease. 
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Living with Coeliac Disease: A Research Study Conducted in  
Partial Fulfilment of the Requirements for the Doctorate in 
Clinical Psychology at the University of Birmingham 
Executive Summary 
 
Coeliac Disease (CD) is an autoimmune disease in which the enzyme gluten causes 
damage and chronic inflammation to the small intestine. Untreated the condition may 
predispose an individual to serious diseases such as cancer, type I diabetes, osteoporosis, 
gynaecological problems in women, central nervous system disorders and other 
autoimmune diseases.  Across Europe it is thought that the condition may affect between 1 
in 200 to 1 in 500 people (Rewers, 2005; Catassi, Ratsch, Fabiani,  1994). CD is cannot be 
cured but symptoms are managed by a gluten-free diet (GFD) for life.       
Most research looking at CD has been focused on the biological basis of the disease 
rather than the impact of the condition from the individual’s own point of view. The few 
existing studies conducted mostly in Europe and Canada suggest that the chronic nature of 
the condition, the limitations imposed by the need to follow a permanent restrictive diet 
and the risk of other associated diseases can have a negative impact on health-related 
quality of life (HRQoL) and psychological well-being (Aldorrato, Leggio, D'Angelo et al, 
2008). There is also a suggestion from the existing literature that women with CD 
experience poorer quality of life than men (Hallert, Sandlund & Broqvist 2003).   
However, knowledge in this area remains sparse to-date particularly in the UK. 
The aim of this research was two-fold: first to systematically review the literature 
published within the last decade to investigate the impact of living with CD on 
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psychological well-being and Health Related Quality of Life (HRQoL) and secondly to 
conduct a questionnaire survey on the Illness Perceptions and Effects of Coeliac Disease 
on Psychological Well-being and HRQoL in a UK Population.  The perceptions that a 
person has about their illness or condition (illness perceptions) give personal meaning to 
symptoms and it is believed they act as a framework for guiding coping strategies.  The 
concept of HRQoL refers to an individual’s perceived state of health including social, 
emotional and physical well-being or functioning.   Psychological well-being is concerned 
with the emotional well-being in individuals whose illnesses or conditions are not so much 
physically incapacitating as psychologically distressing.  The term relates to internal 
emotional states that reflect subjective well-being or distress.   
 
Literature Review 
Twenty-one relevant studies were identified. Eight of these originated from Italy, 
three from Sweden and three from Finland, with the remaining seven coming from 
Germany, the UK, Canada, the USA, Spain, Finland and Argentina.    In general, the 
results of these studies suggest that in addition to a reduced Health Related Quality of Life, 
psychological distress is commonly found in patients with CD, particularly depression.  
The studies showed that anxiety is also commonly experienced but this tends to decrease 
when individuals start a regular gluten-free diet.  However, it was found that depression 
may persist even in people whose diets have been gluten-free for many years.   
 
Questionnaire Survey 
The postal survey investigated self-reported levels of Health Related Quality of Life 
(HRQoL) and psychological (or emotional) well-being in adults belonging to Coeliac UK, 
the main charity supporting people with CD in the UK.   It also explored their beliefs and 
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perceptions concerning CD (illness perceptions) and how well they thought they coped 
with the condition (self-efficacy).  
The survey was ethically approved by the University of Birmingham, School of 
Psychology, Research Ethics Committee and advertised in the quarterly Coeliac UK 
Magazine, ‘Crossed Grain’.  Questionnaires were received back from 288 adult members 
out of a total of 433 who asked to be sent a survey pack.    
The results of the survey in this UK population found that Health Related Quality of 
Life (HRQoL) and psychological well-being were lower than they should be with levels 
being comparable to those found in similar European studies of CD.  Unlike these previous 
studies, in the UK sample there was no evidence to suggest that women have poorer levels 
of HRQoL than men.   
It was also found that those who were not worried by the possible serious 
consequences of CD and who did not react emotionally to their condition tended to have a 
higher level of HRQoL, a healthier level of psychological well-being and increased self-
efficacy (felt they managed their CD well).  Those who strongly believed that they had 
control of their condition and felt they understood their CD well also tended to have higher 
levels of self-efficacy.     
Those participants most likely to stick to a gluten-free diet tended to be older and had 
stronger beliefs in the serious consequences of CD.  The results suggest that knowledge of 
illness perceptions could play an important role in developing psycho-educational 
programmes aimed at helping people stay on gluten-free diets and enhancing psychological 
well-being and HRQoL.  
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Appendix 4 
Questionnaire Pack 
 
 
Participant Information Sheet 
 
Study of Living with Coeliac Disease 
University of Birmingham 
 
Thank you for your interest in this study.  My name is Sarah Ford and I am a 
Clinical Psychologist in Training at the University of Birmingham, UK.  As part 
of my doctoral degree I am conducting a study exploring the experiences of 
individuals who have Coeliac Disease (CD).  I would like to invite you to take 
part in this questionnaire survey.  Please read the information below before 
deciding whether or not you would like to take part in this survey. 
. 
What is the purpose of the study?  Research from other countries suggests 
that a diagnosis of CD and staying on a gluten-free-diet leads to enormous 
changes in the lives of sufferers and the dietary restrictions can be hard to 
accept.  It has been found that some people with CD can feel restricted, 
isolated and at times anxious about what they eat and this reduces their quality 
of life.  So far, no studies have been conducted in the UK to explore the effects 
on adults of living with CD.  Understanding the emotional and social effects of 
having CD may help in the development of effective psychological treatments 
for those who struggle to cope with their disease.  
 
Who is taking part?  All those aged 18 and above who belong to the Coeliac 
Society are being invited to participate.  This is because to be a member you 
need to have been medically diagnosed with CD. 
 
Do I have to take part?  You are under no obligation to participate and you 
have the right to withdraw at any time.  If after completing the survey you 
decide that you would like to withdraw please contact me by email: 
stf615@bham.ac.uk or telephone: 0121 414 7576 and I will destroy your data.   
 
What will happen to me if I take part?  You will be asked to fill in 5 different 
questionnaires. These may take between 20 – 40 minutes to complete. 
 
What do I have to do?  You will be asked to complete 5 questionnaires and 
return them in the envelope provided.  These questionnaires are confidential 
and anonymous. 
 
What are the possible disadvantages and risks of taking part?  The survey 
is completely voluntary and there are no physical risks as I am simply gathering 
information.  Some questions may be a little personal or embarrassing, but you 
do not have to answer any questions you do not want to.   
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What are the possible benefits of taking part?  Participating in this survey 
will not benefit you personally.  However, the findings may help our 
understanding of the effects of CD and help other sufferers in the future. 
 
What happens when the research study stops?  When you send back your 
questionnaires they will be entered into a database accessible only to the 
researchers conducting this study.   It is hoped that this study will be published 
in an academic journal; details will also appear in the Coeliac Society 
Newsletter ‘Crossed Grain’. 
 
• What if I find some of the questions distressing?  If after completing 
this survey you feel in need of some additional support, please speak to 
someone at one of the organisations below: 
 
 
 
? Your GP/practice nurse 
? Coeliac Society helpline: 0870 444 8804 
? NHS Direct Tel: 0845 46 47 
 
 
 
Will my taking part in the study be kept confidential?  All of the information 
that you send will be confidential and anonymous.  When written up all 
participants will be considered as a group so there will be no way of knowing 
who participated in the study. 
 
Contact Details:  Further information can be obtained from Sarah Ford, 
Trainee Clinical Psychologist (email: XXXXXXXX) who is carrying out this 
research under the supervision of Dr Ruth Howard and Dr Jan Oyebode.  They 
can both be contacted at the School of Psychology, University of Birmingham, 
Edgbaston, Birmingham B15 2TT Tel: XXXXXXX 
 
What happens if I decide to take part? Please read and sign the attached 
consent form before completing the five questionnaires. 
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CONSENT FORM        
 
 
Title of Project: Living with Coeliac Disease Study 
 
 
Name of Researcher: Sarah Ford, Trainee Clinical Psychologist 
 
        
I confirm that I have read and understand the information sheet for the above study. I 
have had the opportunity to consider the information, and receive more information (if 
needed) via the contact details given.  
 
I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason. 
 
I agree to take part in the above study.    
 
 
 
Name ________________________________________________________  
 
 
 
Signature_______________________ Date __________________________     
 
 
 
 
 
 
Thank you for agreeing to take part in this survey 
 
Now please complete the five questionnaires 
beginning with form 1  
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Form 1: Living with Coeliac Disease Study 
We are interested in how well you cope with your Coeliac Disease (CD). Please 
indicate how much you agree or disagree with the following statements by circling 
one answer per statement. 
 
 
It is difficult for me to find effective solutions for problems that occur with managing my 
CD. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
        
I find efforts to change things I don’t like about my Coeliac Disease are ineffective. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
I handle myself well with respect to my Coeliac Disease. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
I am able to manage things related to my Coeliac Disease as well as most other 
people. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
I succeed in the projects I undertake to manage my Coeliac Disease. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
Typically, my plans for managing my Coeliac Disease don’t work out well. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
No matter how hard I try, managing my Coeliac Disease doesn’t turn out the way I would 
like. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
 
I’m generally able to accomplish my goals with respect to managing my Coeliac 
Disease. 
 
Strongly         Disagree         Neither agree  Agree          Strongly 
Disagree            nor disagree           Agree 
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 Form 2: Living with Coeliac Disease Study - Illness Perceptions Questionnaire 
 
 
YOUR VIEWS ABOUT YOUR COELIAC DISEASE (CD) 
 
Listed below are a number of symptoms that you may or may not have experienced 
since being diagnosed with CD.  Please indicate by circling Yes or No, whether you 
have experienced any of these symptoms and whether you believe that these 
symptoms are related to your CD. 
                                                          I have experienced this        This symptom is  
                                                          symptom since my CD         related to my CD 
 
Pain      Yes  No ________________ Yes  No 
Sore Throat     Yes  No ________________ Yes  No 
Nausea     Yes  No ________________ Yes  No 
Breathlessness     Yes  No ________________ Yes No 
Weight Loss     Yes  No ________________ Yes  No 
Fatigue     Yes  No ________________ Yes  No 
Stiff Joints     Yes  No ________________ Yes  No 
Sore Eyes     Yes  No ________________ Yes  No 
Wheeziness     Yes  No ________________ Yes  No 
Headaches     Yes  No ________________ Yes  No 
Upset Stomach     Yes  No ________________ Yes  No 
Sleep Difficulties    Yes  No ________________ Yes  No 
Dizziness     Yes  No ________________ Yes  No 
Loss of Strength    Yes  No ________________ Yes  No 
 
We are interested in your own personal views of how you now see your Coeliac 
Disease (CD). Please indicate how much you agree or disagree with the following 
statements about your CD by ticking the appropriate box. 
 
 
VIEWS ABOUT YOUR CD 
 
STRONGLY 
DISAGREE 
 
DISAGREE 
 
NEITHER AGREE 
NOR DISAGREE 
       
AGREE 
 
STRONGLY 
AGREE 
 
My CD will last a short time. 
 
     
My CD is likely to be permanent rather  
than temporary. 
     
My CD will last for a long time. 
 
     
My CD will pass quickly. 
 
     
I expect to have this CD for the rest of  
my life. 
     
My CD is a serious condition. 
 
     
My CD has major consequences on my 
life. 
     
My CD does not have much effect on  
my life. 
     
My CD strongly affects the way others  
see me. 
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FORM 2 Continued/… 
 
VIEWS ABOUT YOUR CD 
 
STRONGLY 
DISAGREE 
 
DISAGREE 
 
NEITHER AGREE 
NOR DISAGREE 
 
AGREE 
  
STRONGLY 
AGREE 
 
My CD has serious financial 
consequences. 
 
     
My CD causes difficulties for those who 
are close to me. 
     
There is a lot which I can do to control 
my 
symptoms. 
     
What I do can determine whether my CD 
gets better or worse. 
     
The course of my CD depends on me. 
 
     
Nothing I do will affect my CD. 
 
     
I have the power to influence my CD. 
 
     
My actions will have no affect on the 
outcome of my CD. 
     
My CD will improve in time. 
 
     
There is very little that can be done to 
improve my CD. 
     
My diet will be effective in curing my CD.
 
     
The negative effects of my CD can be 
prevented (avoided) by my diet. 
     
My diet can control my CD. 
 
     
There is nothing that can help my 
condition. 
 
     
The symptoms of my condition are 
puzzling to me. 
     
My CD is a mystery to me. 
 
     
I don’t understand my CD. 
 
     
My CD doesn’t make any sense to me. 
 
     
I have a clear picture or understanding of 
my condition. 
     
The symptoms of my CD change a great 
deal 
from day to day. 
     
My symptoms come and go in cycles. 
 
     
My CD is very unpredictable. 
 
     
I go through cycles in which my CD gets 
better and worse. 
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         FORM 2 Continued/… 
 
VIEWS ABOUT YOUR CD 
 
 
STRONGLY 
DISAGREE 
 
DISAGREE 
 
NEITHER AGREE 
NOR DISAGREE 
 
AGREE 
 
STRONGLY 
DISAGREE   
I get depressed when I think about my CD.
 
     
When I think about my CD I get upset. 
 
     
My CD makes me feel angry. 
 
     
My CD does not worry me. 
 
     
Having this CD makes me feel anxious. 
 
     
My CD makes me feel afraid. 
 
     
 
CAUSES OF MY COELIAC DISEASE 
 
We are interested in what you consider may have been the cause of your CD. As people are very 
different, there is no correct answer for this question. We are most interested in your own views 
about the factors that caused your CD rather than what others including doctors or family may 
have suggested to you. Below is a list of possible causes for your CD. Please indicate how much 
you agree or disagree that they were causes for you by ticking the appropriate box. 
 
POSSIBLE CAUSES 
 
 
STRONGLY 
DISAGREE       
 
DISAGREE 
 
NEITHER AGREE 
NOR DISAGREE 
 
AGREE 
 
STRONGLY 
AGREE 
Stress or worry. 
 
     
Hereditary - it runs in my family. 
 
     
A Germ or virus. 
 
     
Diet or eating habits. 
 
     
Chance or bad luck. 
 
     
Poor medical care in my past. 
 
     
Pollution in the environment. 
 
     
My own behaviour. 
 
     
My mental attitude e.g. thinking about 
life negatively. 
     
Family problems or worries. 
 
     
Overwork. 
 
     
My emotional state e.g. feeling down, 
lonely, 
anxious, empty. 
     
Ageing. 
 
     
                                                                                                                                               97
 
                                                                                                                                               98
 
FORM 2 Continued/… 
 
 
               
POSSIBLE CAUSES 
 
 
STRONGLY 
DISAGREE       
 
DISAGREE 
 
NEITHER AGREE 
NOR DISAGREE 
 
AGREE 
 
STRONGLY 
AGREE 
Alcohol. 
 
     
Smoking. 
 
     
Accident or injury. 
 
     
My personality. 
 
     
Altered immunity. 
 
     
 
 
 
Below, please list in rank-order the three most important factors that you now believe caused 
YOUR CD. You may use any of the items from the box above, or you may have additional ideas of 
your own. 
 
The most important causes for me: 
 
1. _______________________________________ 
 
 
2. ________________________________________ 
 
 
3. _______________________________________ 
 
 
 
 
Thank you   
Please continue by completing form 3 
on the back of this page   → 
 
 
Form 3: The General Well-Being Index (British version) 
 
      Please tick the column which best applies to you (one answer per row) 
 
How have you been feeling in general 
during the past month? 
 
In very good 
spirits 
 
In good 
spirits mostly
 
I’ve been up 
& down a lot
  
In low spirits 
mostly 
 
 
In very 
low spirits 
 
          
During the past month have you been 
bothered by any Illness, pains or fears 
about your health? 
All the time 
 
 
A lot of the 
time 
 
Some of the 
time 
 
A little bit 
 
 
Not at all 
 
 
           
Did you feel depressed during the 
past month? 
 
Yes, very 
much so 
 
Yes, quite a 
bit 
 
Sometimes 
enough to 
bother me 
A little 
depressed 
now and then 
No, not at all 
 
 
           
During the past month have you felt in 
firm control of your actions, thoughts 
or feelings? 
Yes, definitely
  
Yes, mostly 
 
Not too well
 
No, hardly at 
all 
 
Not at all 
 
           
Have you been bothered by your 
nerves during the past month?  Very much so Quite a bit Sometimes A little Not at all 
           
During the past month how much 
energy or vitality did you have? 
 
Lots of energy
  
Fairly 
energetic 
most of the 
time 
Energy 
varied quite a 
bit 
Low in 
energy 
mostly 
No energy  
at all  
           
Have you felt disheartened and sad 
over the past month?  All of the time
Most of the 
time 
From time to 
time 
Very 
occasionally Not at all 
           
During the past month how tense 
have you been?  
Extremely 
tense all of the 
time 
Very tense 
most of the 
time 
A little tense 
sometimes 
Rarely tense  
 
Not tense  
at all 
           
 
 
 
 
   
FORM 3 Continued/… 
 
hHow happy or satisfied have you 
been with your personal life during 
the past month?  
Very satisfied
 
Fairly 
satisfied 
Satisfied on 
the whole 
Rather 
dissatisfied 
Very 
dissatisfied 
           
Over the past month did you feel well 
enough to do the things you like to do 
or had to? 
Yes, definitely 
 
Yes, for the 
most part 
 
About half 
the time 
 
No, not often 
 
No, not at all  
 
           
Have you felt so sad, disheartened or 
had so many problems that you 
wondered if anything was worthwhile 
over the past month? 
All the time 
 
 
Most of the 
time 
 
From time to 
time 
 
Very 
Occasionally 
 
Not at all 
 
 
           
During the past month have you been 
waking up feeling fresh and rested? 
Every day 
 
Most days 
 
Less than 
half the time
Not often 
 
Not at all 
 
           
Have you had any worries or fears 
about your health during the past 
month? 
Yes, all the 
time 
Most of the 
time 
From time to 
time 
Not a lot 
 
Not at all 
 
           
During the past month have you 
wondered if you were losing control 
over your actions, thoughts, feelings 
or memory? 
All the time 
 
 
Most of the 
time 
 
From time to 
time 
 
 
 
No, hardly at 
all 
 
Not at all 
 
 
           
Has your daily life been filled with 
things that interest you during the 
past month? 
All of the time 
 
 
Most of the   
time 
 
Some of the 
time 
 
A little 
 
 
Not at all 
 
 
           
During the past month how active and 
vigorous have you felt? 
  
Very active 
every day 
 
Mostly active
  
Fairly active
 
Seldom 
active 
 
Not at all 
active 
 
           
Have you been anxious, worried, or 
upset over the past month? 
 
Very much so 
 
Quite a lot 
 
Sometimes 
enough to 
bother me 
A little bit 
 
Not at all 
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FORM 3 Continued/… 
 
 
During the past month have you felt 
emotionally stable and sure of 
yourself? All of the time
Most of the 
time 
Some of the 
time 
Now and 
then Not at all 
      
How relaxed have you felt over the 
past month? 
 
Very relaxed  
all the time 
Mostly 
relaxed 
Relaxed 
about half the 
time 
Rarely felt 
relaxed 
Not at all 
relaxed 
      
During the past month how cheerful  
have you been? 
 
Not cheerful at 
all 
A little 
cheerful now 
and then 
Cheerful 
about half the 
time 
Mostly quite 
cheerful 
Very cheerful 
all the time 
            
Have you felt tired, worn out or 
exhausted during the past month? All of the time
Most of the 
time 
Some of the 
time 
Now and 
then Not at all 
           
Over the past month have you been 
under any stress or pressure? 
 
Yes, almost 
more than I 
could bear 
Yes, more 
than usual 
 
About the 
same as 
usual 
Yes, a little 
 
No, not at all 
 
      
 
 
 
 
 
 
Thank you 
Please continue by completing form 4 
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FORM 4 
The Coeliac Disease Questionnaire CDQ – Health related quality of life index   
 
This questionnaire has been developed to find out how you have been feeling during the last two 
weeks. You will be asked about symptoms related to your coeliac disease, your general well-being and 
your mood. The questionnaire contains 28 questions. Each question offers seven possible answers 
ranked (1) to (7). Please read each question carefully and circle the answer that best describes how 
you felt during the past two weeks. 
 
 
How many times during the past two weeks was your life affected by a sudden urge to visit a  
bathroom for a bowel movement?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How often during the last two weeks did you feel physically exhausted or fatigued? 
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How often during the last two weeks have you felt frustrated, impatient or restless?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you refuse or avoid an invitation for dinner with  
friends or relatives due to your coeliac disease?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How often during the last two weeks have your bowel movements been loose? 
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How much intellectual energy did you have during the last two weeks?  
 
No energy      Very little     Little energy      Some energy      A moderate     Lots of       I was full 
At all      energy              amount of      energy        of energy 
                  energy 
How many times during the last two weeks were you concerned that your children could inherit or may 
have inherited your coeliac disease?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
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How many times during the last two weeks have you been troubled by cramps in your abdomen?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time  
 
Did you encounter any difficulties with recreational activities or sports due to your coeliac disease  
during the last two weeks?  Please tick one answer below. 
 
 
? Extreme difficulties, no activities possible 
? Very considerable difficulties 
? Considerable difficulties 
? Some difficulties 
? Minor difficulties 
? Hardly any difficulties 
? No difficulties, coeliac disease did not affect my recreational activities or sports 
 
 
How often during the last two weeks did you feel depressed or discouraged? 
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time  
 
How many times during the last two weeks did you suffer from bloating or flatulence?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
People with coeliac disease often have worries and fears related to their disease. How many times  
during the last two weeks did you worry about or were afraid of getting cancer as a result of your CD?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks were you affected by a feeling of incomplete bowel 
evacuation?  
 
All of the  Most of A good bit Some of A little  Hardly any None of     
Time the time of the time the time of the time of the time the time 
 
How often during the last two weeks have you felt relaxed and free of tension?  
 
None of   Hardly any A little  Some of A good bit Most of All of 
the time of the time of the time the time of the time the time the time 
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How many times during the last two weeks did you feel isolated from or excluded by others due  
to your coeliac disease?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
 
How much of the time during the last two weeks have you felt tearful or upset?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you suffer from repeated belching?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
 
To what extent did your CD restrict your sexual activity during the last two weeks?  
 
? No sex due to coeliac disease 
? Considerable restraint due to coeliac disease 
? Moderate restraint due to coeliac disease 
? Some restraint due to coeliac disease 
? Little restraint due to coeliac disease 
? Almost no restraint due to coeliac disease 
? No restraint due to coeliac disease 
 
 
How many times during the last two weeks did you suffer from nausea or retching?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you feel that important people such as members of 
your family or friends showed a lack of understanding for your CD?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
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How satisfied, happy or pleased have you been with your personal life you during the last two weeks? 
 
? Very unsatisfied, mostly unhappy 
? Generally unsatisfied, unhappy 
? Somewhat unsatisfied, unhappy 
? Generally satisfied, pleased 
? Most of the time satisfied, happy 
? Most of the time very satisfied, happy  
? Very satisfied, could not be happier or more pleased   
 
How many times during the last two weeks did you feel that colleagues or superiors showed a  
lack of understanding for your coeliac disease?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you feel limited in your professional training or  
career by your coeliac disease?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you feel burdened by the expenses and time required 
obtaining gluten-free food? 
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you feel burdened by problems with meeting the   
costs of gluten-free food or other coeliac therapies?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you experience lack of expertise regarding CD  
from your doctors?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
How many times during the last two weeks did you worry that your CD was diagnosed too late?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
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How many times during the last two weeks did you suffer from fear of medical examinations in  
relation to your coeliac disease, e.g. blood test or endoscopy?  
 
All of the  Most of A good bit Some of A little  Hardly any None of 
Time the time of the time the time of the time of the time the time 
 
 
 
 
 
Thank you 
Please continue by completing form 5 
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Form 5: Living with Coeliac Disease Study – Information About You 
 
Please state your date of birth: Day………… Month…………….. Year ……………...  
 
Are you:  Female  Male            (please tick) 
 
Marital Status (please tick as applicable) 
? Single (never married)   
? Married 
? Co-habiting 
? Separated 
? Divorced 
? Widowed 
 
Ethnicity: 
 
? White British 
? Asian 
? Black 
? Chinese 
? Mixed – White & Asian 
? Mixed – White & Black 
? Other mixed background 
? Any other ethnic background 
 
Age at diagnosis of Coeliac Disease 
? Childhood 5 – 10 years old 
? Adolescence 11 – 20 years old 
? Adulthood 21 – 30 years old 
? Adulthood 31 – 40 years old 
? Adulthood 41 – 50 years 
? Adulthood 50 +    
 
Education Level: 
? School education, no qualifications 
? School education with qualifications 
? University qualifications 
? Vocational training/qualifications 
 
 
 
Highest Occupation: 
? Professional occupation 
? Managerial or technical 
? Non-manual skilled 
? Manual skilled 
? Partly skilled 
? Unskilled occupation 
? Home-maker 
 
 
How many years since your CD 
diagnosis? 
 
? Less than a year 
? 1 year - 5 years 
? 6 years – 10 years 
? 11 years – 20 years 
? 21 years – 30 years 
? 31 years – 40 years 
? More than 40 years 
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FORM 5 Continued/… 
 
 
 
In general, how strictly do you maintain a 
gluten free diet? 
 
? All of the time 
? Most of the time 
? Some of the time 
? Now and then 
? Not at all 
 
 
 
How long have you been a member 
of Coeliac UK? 
 
? Less than a year 
? 1 year - 5 years 
? 6 years – 10 years 
? 11 years – 20 years 
? More than 20 years 
 
 
 
 
Thank you for taking the time to complete this 
survey. Your participation is much appreciated. 
 
 
Please post all the forms (apart from the 
information sheet) back to us using the envelope 
provided.  Please check that you have filled in both 
sides of each form and remember to include the 
consent form, as we cannot process your forms 
without this.
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Appendix 7 
  
One-Sample Kolmogorov-Smirnov Test 
  
 PMCSMS  
Total Score 
IPQ-R 
Identity 
  IPQ-R        
Timeline 
 
IPQ-R 
Consequences 
N 280 278 278 278
Normal Parameters(a,b) Mean 31.76 3.37 28.19 21.04
  Std. Deviation 5.948 2.940 2.400 4.927
Most Extreme Diffs Absolute .105 .148 .225 .113
  Positive .083 .148 .225 .057
  Negative -.105 -.126 -.200 -.113
Kolmogorov-Smirnov Z 1.763 2.496 3.758 1.883
Asymp. Sig. (2-tailed) .004 .000 .000 .002
a  Test distribution is Normal. 
b  Calculated from data. 
 
 
 One-Sample Kolmogorov-Smirnov Test 
  
IPQ-R 
Personal 
Control 
IPQ-R 
Treatment 
Control 
IPQ-R  
Illness 
Coherence 
IPQ-R 
Timeline 
Cyclical 
N 278 278 278 278
Normal Parameters(a,b) Mean 26.03 19.74 21.31 9.12
  Std. Deviation 4.060 3.327 4.128 4.358
Most Extreme Diffs Absolute .164 .113 .196 .170
  Positive .164 .072 .185 .170
  Negative -.152 -.113 -.196 -.120
Kolmogorov-Smirnov Z 2.738 1.889 3.272 2.834
Asymp. Sig. (2-tailed) .000 .002 .000 .000
a  Test distribution is Normal. 
b  Calculated from data. 
 
 
 One-Sample Kolmogorov-Smirnov Test 
  
IPQ-R 
Emotional 
Responses 
IPQ-R 
Psychological
Factors 
IPQ-R  
Risk 
 Factors 
IPQ-R 
Immunity
N 278 278 278 278
Normal Parameters(a,b) Mean 15.35 12.40 15.27 7.49
  Std. Deviation 5.858 9.141 8.502 8.587
Most Extreme Diffs Absolute .105 .231 .206 .319
  Positive .105 .144 .206 .319
  Negative -.067 -.231 -.189 -.297
Kolmogorov-Smirnov Z 1.750 3.795 3.374 5.023
Asymp. Sig. (2-tailed) .004 .000 .000 .000
a  Test distribution is Normal. 
b  Calculated from data. 
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One-Sample Kolmogorov-Smirnov Test 
  
IPQ-R 
Accident/ 
Chance 
GWBI 
Total 
Score 
CDQ Total 
Score AGE 
N 278 274 276 279
Normal Parameters(a,b) Mean 4.83 78.17 152.28 54.0758
  Std. Deviation 8.140 15.468 26.493 14.68605
Most Extreme Diffs Absolute .369 .065 .114 .073
  Positive .369 .034 .065 .045
  Negative -.350 -.065 -.114 -.073
Kolmogorov-Smirnov Z 6.218 1.071 1.902 1.227
Asymp. Sig. (2-tailed) .000 .202 .001 .098
a  Test distribution is Normal. 
b  Calculated from data. 
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